General Information of Disease (ID: DIS2YIMD)

Disease Name Tuberculosis
Synonyms Kochs disease; TB; active tuberculosis; tuberculosis disease
Disease Class 1B10-1B14: HIV-infected patients with tuberculosis
Definition
A chronic, recurrent infection caused by the bacterium Mycobacterium tuberculosis. Tuberculosis (TB) may affect almost any tissue or organ of the body with the lungs being the most common site of infection. The clinical stages of TB are primary or initial infection, latent or dormant infection, and recrudescent or adult-type TB. Ninety to 95% of primary TB infections may go unrecognized. Histopathologically, tissue lesions consist of granulomas which usually undergo central caseation necrosis. Local symptoms of TB vary according to the part affected; acute symptoms include hectic fever, sweats, and emaciation; serious complications include granulomatous erosion of pulmonary bronchi associated with hemoptysis. If untreated, progressive TB may be associated with a high degree of mortality. This infection is frequently observed in immunocompromised individuals with AIDS or a history of illicit IV drug use.
Disease Hierarchy
DIS8ZVFW: Primary bacterial infectious disease
DISNSMUD: Mycobacterium infection
DISEM33Q: Infectious disease
DIS2YIMD: Tuberculosis
ICD Code
ICD-11
ICD-11: 1B10-1B14
Disease Identifiers
MONDO ID
MONDO_0018076
MESH ID
D014376
UMLS CUI
C0041296
MedGen ID
22513
Orphanet ID
3389
SNOMED CT ID
371569005

Drug-Interaction Atlas (DIA) of This Disease

Drug-Interaction Atlas (DIA)
This Disease is Treated as An Indication in 8 Approved Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
Cycloserine DMT1I52 Approved Small molecular drug [1]
Ethionamide DM8K3EI Approved Small molecular drug [2]
Isoniazid DM5JVS3 Approved Small molecular drug [3]
Moxifloxacin DMU8V4S Approved Small molecular drug [4]
Pretomanid DMDYA31 Approved Small molecular drug [5]
Rifabutin DM1YBHK Approved Small molecular drug [1]
Sulfamethoxazole DMB08GE Approved Small molecular drug [6]
Trimethoprim DMM7CHK Approved Small molecular drug [7]
------------------------------------------------------------------------------------
⏷ Show the Full List of 8 Drug(s)
This Disease is Treated as An Indication in 12 Clinical Trial Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
Immunoxel DMT09TV Phase 3 NA [8]
Sudapyridine DMCERAB Phase 3 Small molecule [9]
BTZ-043 DMVXBSW Phase 2 Small molecule [10]
GSK098 DMROM2A Phase 2 NA [11]
GSK3036656 DMCDAVK Phase 2 Small molecular drug [12]
TBA-7371 DMZTOJ6 Phase 2 Small molecular drug [13]
OPC-167832 DMZB6LO Phase 1/2 Small molecular drug [14]
BNT164 DMCQIQR Phase 1 Vaccine [15]
GSK2556286 DM7PGOJ Phase 1 Small molecule [16]
TBA-354 DM9AV14 Phase 1 Small molecular drug [17]
TBAJ-587 DMCIPP7 Phase 1 Small molecule [18]
TBI-223 DMP9HHO Phase 1 Small molecule [19]
------------------------------------------------------------------------------------
⏷ Show the Full List of 12 Drug(s)
This Disease is Treated as An Indication in 5 Preclinical Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
FNDR 20364 DMN0WK4 Preclinical NA [20]
GSK839 DMI9K37 Preclinical NA [20]
MBX-4888A DMDHFTW Preclinical NA [20]
OTB-658 DMFG7CC Preclinical Small molecule [21]
TB47 DMPGIWT Preclinical Small molecule [22]
------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)
This Disease Is Related to 251 DTT Molecule(s)
Gene Name DTT ID Evidence Level Mode of Inheritance REF
CES1 TTMF541 Limited Biomarker [23]
CTSG TTQAJF1 Limited Altered Expression [24]
DUT TTH6MBO Limited Biomarker [25]
ENPEP TT9PBIL Limited Biomarker [26]
GABRQ TTXDUR9 Limited Genetic Variation [27]
GLO1 TTV9A7R Limited Genetic Variation [28]
KIR2DL2 TTU0P73 Limited Genetic Variation [29]
KIR2DL3 TTEX3SI Limited Biomarker [29]
KIR2DS2 TTV3CFI Limited Biomarker [30]
PSMB9 TTOUSTQ Limited Genetic Variation [31]
RPGR TTHBDA9 Limited Biomarker [32]
RPS12 TTD81N3 Limited Genetic Variation [33]
SLC11A2 TT2IS7P Limited Genetic Variation [34]
TMPRSS11D TTWHYC8 Limited Biomarker [35]
UBE3A TTUZX6V Limited Genetic Variation [36]
UTS2R TTW5UDX Limited Genetic Variation [37]
ADAMTS4 TTYG6BU Disputed Altered Expression [38]
APCS TTB7VAT Disputed Altered Expression [39]
ARSB TTESQTG Disputed Altered Expression [40]
CD1A TTBGTFN Disputed Biomarker [41]
CLEC4C TT7YT06 Disputed Biomarker [42]
GMPS TTCFP0V Disputed Biomarker [43]
IFNAR2 TTMQB37 Disputed Biomarker [44]
IL3RA TTENHJ0 Disputed Biomarker [42]
LY75 TTG180Q Disputed Biomarker [45]
MSR1 TT2TDH9 Disputed Genetic Variation [46]
PROC TTZUXYS Disputed Biomarker [47]
PTP4A3 TT7YM8D Disputed Biomarker [48]
SLC40A1 TT6Y1PG Disputed Genetic Variation [49]
AIMP2 TTXWHGF moderate Biomarker [50]
CCR5 TTJIH8Q moderate Biomarker [51]
CD163 TTTZ9DE moderate Biomarker [52]
CD9 TTZEIBV moderate Biomarker [53]
CRK TTFEUYR moderate Biomarker [50]
EBI3 TTJF68X moderate Genetic Variation [54]
GEM TTAZF9M moderate Biomarker [55]
HAMP TTRV5YJ moderate Biomarker [56]
HSPE1 TTWYMFE moderate Biomarker [57]
IL13 TT0GVCH moderate Biomarker [58]
IL17D TTC5LTG moderate Biomarker [59]
IL32 TTD4G7L moderate Biomarker [60]
IRF1 TT4TU3L moderate Biomarker [61]
MASP2 TTR01E9 moderate Genetic Variation [62]
TLR6 TTWRI8V moderate Genetic Variation [63]
ABCA4 TTLB52K Strong Genetic Variation [64]
ACR TTAHE2N Strong Biomarker [65]
ADAM9 TTTYQNS Strong Altered Expression [66]
ADK TTL732K Strong Biomarker [67]
ADRA1D TT34BHT Strong Biomarker [68]
AGTR2 TTQVOEI Strong Genetic Variation [69]
ALDH5A1 TTJUWVB Strong Altered Expression [70]
ALOX15 TTN9T81 Strong Biomarker [71]
AMACR TTLN1AP Strong Biomarker [72]
APEH TTYWEDQ Strong Biomarker [73]
ARAF TT5TURO Strong Altered Expression [74]
ATP2A2 TTE6THL Strong Biomarker [68]
ATP6AP1 TTWDM4U Strong Biomarker [75]
BACH1 TT2ME4S Strong Genetic Variation [76]
BTLA TTER58P Strong Biomarker [77]
CASP4 TT6KIOT Strong Biomarker [78]
CCL20 TT2XAZY Strong Altered Expression [79]
CCL22 TTBTWI1 Strong Altered Expression [80]
CCL3 TT8I4WB Strong Biomarker [81]
CCR2 TTFZYTO Strong Biomarker [82]
CCR4 TT7HQD0 Strong Biomarker [83]
CCR6 TTFDB30 Strong Altered Expression [84]
CD27 TTDO1MV Strong Biomarker [85]
CD83 TTT9MRQ Strong Altered Expression [86]
CD86 TT53XHB Strong Altered Expression [87]
CDA TTQ12RK Strong Biomarker [88]
CDK5R1 TTBYM6V Strong Biomarker [89]
CEBPA TT5LWG1 Strong Biomarker [90]
CEBPB TTUI35N Strong Genetic Variation [91]
CEL TTTRNQW Strong Biomarker [92]
CEP290 TT3XBOV Strong Genetic Variation [93]
CFD TT8D13I Strong Biomarker [94]
CHIT1 TTDYX6T Strong Biomarker [95]
CLEC6A TTQ02HK Strong Biomarker [96]
CLEC9A TTGUSRB Strong Altered Expression [97]
CR1 TTEA8OW Strong Genetic Variation [98]
CSE1L TTTRULD Strong Biomarker [99]
CXCL13 TT0NIZ1 Strong Biomarker [100]
CXCL9 TTWE5PB Strong Genetic Variation [101]
CXCR3 TT1UCIJ Strong Altered Expression [84]
CYBB TT5T8MR Strong Biomarker [102]
CYP2C19 TTZ58XG Strong Biomarker [103]
CYP2C9 TTR40YJ Strong Biomarker [104]
CYP3A4 TTWP7HQ Strong Biomarker [105]
CYP3A5 TTHS0OK Strong Genetic Variation [106]
CYP51A1 TT67TDP Strong Biomarker [107]
DEFB4A TTIVY12 Strong Altered Expression [108]
DHFR TTYZVDJ Strong Biomarker [109]
ELK3 TT5OJMV Strong Biomarker [110]
EPX TTCIO0M Strong Biomarker [111]
EREG TTYSB89 Strong Genetic Variation [112]
ERF TTGXULC Strong Biomarker [113]
FCGR2B TT5RWKQ Strong Biomarker [114]
FDXR TT3W4IX Strong Genetic Variation [115]
FTH1 TT975ZT Strong Biomarker [116]
GALE TTGRHIB Strong Biomarker [117]
GALNS TTT9YPO Strong Biomarker [118]
GAPDH TTUGSWA Strong Biomarker [119]
GAST TT4LRVO Strong Biomarker [118]
GLA TTIS03D Strong Biomarker [120]
GLUL TTURQ2G Strong Biomarker [121]
GZMB TTKEPHX Strong Biomarker [122]
HCN1 TTNB6UQ Strong Biomarker [123]
HDAC11 TT8K17W Strong Altered Expression [124]
HLA-DQB2 TTL7VOU Strong Genetic Variation [125]
HP TTLC8E1 Strong Biomarker [126]
HRC TTR4FKD Strong Biomarker [127]
HSPG2 TT5UM29 Strong Genetic Variation [128]
HTRA1 TT8POQR Strong Genetic Variation [129]
IFNAR1 TTSYFMA Strong Biomarker [130]
IFNB1 TT4TZ8J Strong Biomarker [131]
IL12RB2 TT4SWR8 Strong Altered Expression [132]
IL15 TTJFA35 Strong Altered Expression [133]
IL1R2 TT51DEV Strong Genetic Variation [134]
IL20 TTNZMY2 Strong Biomarker [135]
IL21 TT9QEJ6 Strong Biomarker [136]
IL21R TTZO9B0 Strong Biomarker [137]
IL23R TT6H4QR Strong Genetic Variation [138]
IL5 TTPREZD Strong Biomarker [139]
IL5RA TTXH9AD Strong Biomarker [140]
IL7 TT8FRMO Strong Altered Expression [141]
IL9 TT0JTFD Strong Biomarker [142]
IMPDH2 TTTB4UP Strong Biomarker [143]
IRAK3 TTBPJOK Strong Biomarker [144]
IRAK4 TTILUKB Strong Biomarker [145]
IRF8 TTHUBNK Strong Biomarker [146]
ISG15 TTVOH3T Strong Biomarker [147]
ITGA1 TTPERWV Strong Biomarker [148]
KIR2DL1 TT4UXPE Strong Altered Expression [149]
KIR2DS1 TTVWAGF Strong Altered Expression [149]
KIR3DL2 TTQH3N0 Strong Biomarker [150]
KLRG1 TT299E6 Strong Biomarker [151]
KLRK1 TTLRN4A Strong Altered Expression [152]
KMT5A TTGC95K Strong Biomarker [153]
LAG3 TTNVXAW Strong Biomarker [154]
LAMB3 TT2WOUQ Strong Biomarker [155]
LAMP1 TTC214J Strong Altered Expression [156]
LANCL1 TTZW8NS Strong Altered Expression [157]
LILRB1 TTC0QRJ Strong Biomarker [158]
LILRB2 TTHC6XU Strong Biomarker [158]
LIPE TTLUQ8E Strong Biomarker [159]
LPA TTU9LGY Strong Biomarker [160]
LTA4H TTXZEAJ Strong Genetic Variation [161]
LTB TTHQ6US Strong Biomarker [162]
LYZ TTAOZBW Strong Biomarker [163]
MAP3K14 TT4LIAC Strong Biomarker [164]
MAS1 TTOISYB Strong Genetic Variation [165]
MBP TT2RY5P Strong Biomarker [166]
MBTPS1 TTNSM2I Strong Biomarker [167]
MC3R TTNI91K Strong Genetic Variation [168]
METAP1 TT1L79K Strong Biomarker [169]
MIF TT6804T Strong Genetic Variation [170]
MLYCD TT9Z4YD Strong Biomarker [171]
MMP10 TTXLEG7 Strong Biomarker [172]
MOG TTQAFX5 Strong Genetic Variation [173]
MRC1 TTKV8W5 Strong Biomarker [174]
MSTN TTM8I2X Strong Genetic Variation [175]
MUC16 TTC1PS3 Strong Biomarker [176]
MYD88 TTB6Q2O Strong Genetic Variation [63]
NCR1 TTQNRJM Strong Biomarker [177]
NEDD4 TT1QU6G Strong Biomarker [178]
NOTCH4 TTXDIK2 Strong Genetic Variation [179]
NR1I2 TT7LCTF Strong Altered Expression [180]
OXSM TT1AL3P Strong Biomarker [181]
PBK TTMY6BZ Strong Biomarker [164]
PDCD1LG2 TTW14O3 Strong Biomarker [182]
PDE8A TTIS4OW Strong Biomarker [183]
PHGDH TT8DRCK Strong Biomarker [184]
PLA2G2A TTO8QRU Strong Biomarker [185]
PNP TTMCF1Y Strong Biomarker [186]
PPID TTNAFOU Strong Biomarker [187]
PPIF TTRFQTB Strong Biomarker [187]
PPM1A TTLA7IX Strong Biomarker [188]
PPP2CA TTHTKNY Strong Altered Expression [189]
PRDX5 TTLPJWH Strong Biomarker [190]
PRKCD TT7A1BO Strong Biomarker [191]
PSMB8 TTEAD9J Strong Genetic Variation [192]
PTBP1 TTWMX0U Strong Biomarker [193]
PTPRB TT64I9Q Strong Biomarker [194]
RGS12 TTP9AV7 Strong Genetic Variation [195]
RGS6 TTJ96M8 Strong Biomarker [196]
RIPK2 TTCQ2E5 Strong Genetic Variation [197]
RORC TTGV6LY Strong Biomarker [198]
RPSA TTLUW5B Strong Altered Expression [157]
S100A6 TT716MY Strong Biomarker [199]
S1PR2 TTVSMOH Strong Biomarker [167]
SDHD TTVH9W8 Strong Biomarker [200]
SFTPD TTGLMU7 Strong Biomarker [201]
SLC17A5 TTFSUIA Strong Biomarker [202]
SLCO1B1 TTFGXEB Strong Genetic Variation [203]
SMPD1 TTJTM88 Strong Biomarker [204]
SMPD2 TTE5VI6 Strong Biomarker [204]
SOCS1 TT8COJM Strong Biomarker [205]
SOST TTYRO4F Strong Biomarker [88]
SPN TTOZAX0 Strong Genetic Variation [206]
TAP1 TT7JZI8 Strong Genetic Variation [207]
TBX21 TTNF9PH Strong Altered Expression [208]
TLR7 TTRJ1K4 Strong Biomarker [209]
TLR8 TT8CWFK Strong Genetic Variation [210]
TNFRSF18 TTG6LA7 Strong Altered Expression [100]
TNFRSF9 TTPW9LJ Strong Biomarker [211]
TPP1 TTOVYPT Strong Biomarker [212]
TST TT51OTS Strong Biomarker [213]
TXN TTZJ5U9 Strong Biomarker [214]
TXNRD1 TTR7UJ3 Strong Biomarker [215]
UGT1A1 TT34ZAF Strong Biomarker [216]
UMPS TTAFJUD Strong Biomarker [217]
VKORC1 TTEUC8H Strong Biomarker [218]
VTCN1 TTCK85E Strong Altered Expression [86]
ABCB11 TTUXCAF Definitive Biomarker [219]
ADA TTLP57V Definitive Biomarker [220]
AGRP TT4DE1O Definitive Biomarker [221]
AHCY TTE2KUJ Definitive Biomarker [222]
ALOX12 TT12ABZ Definitive Altered Expression [223]
ALPI TTHYMUV Definitive Biomarker [224]
ATP4A TTF1QVM Definitive Biomarker [225]
CCR1 TTC24WT Definitive Genetic Variation [226]
CFP TTLA0VS Definitive Biomarker [227]
CRP TTWRN6M Definitive Biomarker [228]
CXCL11 TTWG0RE Definitive Genetic Variation [101]
CYP2B6 TTMH124 Definitive Genetic Variation [229]
CYP2E1 TTWVHQ5 Definitive Genetic Variation [230]
DUSP3 TTIFAYS Definitive Biomarker [231]
DUSP5 TTZN92A Definitive Biomarker [232]
FGFBP1 TTV1YFT Definitive Altered Expression [233]
GOT1 TTU507L Definitive Biomarker [234]
GRB2 TTEYRJ9 Definitive Biomarker [235]
GRIK1 TT0MYE2 Definitive Genetic Variation [236]
GRIK3 TTNP6O2 Definitive Genetic Variation [236]
IFNL3 TTRF4Q2 Definitive Biomarker [237]
IL22 TTLDX4N Definitive Biomarker [238]
IL2RB TT9721Y Definitive Genetic Variation [239]
IL31 TT1RJXK Definitive Biomarker [198]
MAGEC2 TTKGUEB Definitive Biomarker [240]
PTGER2 TT1ZAVI Definitive Genetic Variation [241]
RBCK1 TTIKUVC Definitive Biomarker [242]
REL TT1ZCTH Definitive Biomarker [243]
RICTOR TT143WL Definitive Biomarker [244]
SERPINC1 TT4QPUL Definitive Biomarker [245]
SLC10A1 TTWZRY5 Definitive Biomarker [246]
SOCS3 TTI0ME6 Definitive Biomarker [247]
TBK1 TTMP03S Definitive Biomarker [248]
TLR1 TTW14D0 Definitive Genetic Variation [63]
TLR9 TTSHG0T Definitive Biomarker [249]
TOP2A TTCGY2K Definitive Biomarker [250]
ULK1 TT4D7MJ Definitive Biomarker [251]
VDAC1 TTAMKGB Definitive Biomarker [252]
------------------------------------------------------------------------------------
⏷ Show the Full List of 251 DTT(s)
This Disease Is Related to 11 DTP Molecule(s)
Gene Name DTP ID Evidence Level Mode of Inheritance REF
SLC22A4 DT2EG60 Limited Genetic Variation [253]
SLC22A5 DT3HUVD Limited Genetic Variation [253]
SLCO6A1 DTIFXNS moderate Biomarker [254]
SLC14A2 DT8QC7K Strong Genetic Variation [255]
SLC25A3 DTCRIWV Strong Biomarker [256]
SLC27A5 DT0TQS3 Strong Biomarker [92]
SLC2A13 DT0NSKB Strong Biomarker [257]
SLC34A1 DT42EWA Strong Genetic Variation [258]
SLC9A6 DTN0JXW Strong Genetic Variation [259]
ATP12A DT5NLZA Definitive Biomarker [225]
SLC39A8 DTLPQGT Definitive Biomarker [260]
------------------------------------------------------------------------------------
⏷ Show the Full List of 11 DTP(s)
This Disease Is Related to 26 DME Molecule(s)
Gene Name DME ID Evidence Level Mode of Inheritance REF
CYP4F3 DEFCMPI Limited Genetic Variation [261]
GSTZ1 DEQPEMB Limited Biomarker [262]
LDHC DEQG7F9 Limited Biomarker [263]
ADH4 DEOCWU3 Strong Biomarker [264]
ALDH1A2 DEKN1H4 Strong Altered Expression [265]
CMPK1 DEMPH4I Strong Biomarker [266]
CYP27B1 DE3FYEM Strong Altered Expression [267]
CYP7A1 DEDZRQ1 Strong Genetic Variation [268]
DTYMK DEOTVYU Strong Genetic Variation [269]
FMO2 DEIASEZ Strong Biomarker [270]
FPGS DECWT2V Strong Biomarker [271]
GPT DER5HFI Strong Biomarker [272]
GSTM1 DEYZEJA Strong Biomarker [273]
LARS2 DEP7BTH Strong Biomarker [274]
MARS1 DE0K52I Strong Biomarker [274]
MT1A DE5ME8A Strong Biomarker [275]
NDUFS3 DE741FI Strong Genetic Variation [276]
NT5C2 DE1DOKJ Strong Biomarker [277]
PGM1 DEA3VM1 Strong Genetic Variation [28]
SAT1 DEMWO83 Strong Biomarker [278]
UGT2B7 DEB3CV1 Strong Genetic Variation [279]
UPP1 DEFZWAX Strong Biomarker [280]
UPRT DE20ETR Strong Biomarker [280]
BAAT DERA3OF Definitive Genetic Variation [281]
CYP2R1 DEBIHM3 Definitive Genetic Variation [282]
TGM6 DEUWCVD Definitive Genetic Variation [283]
------------------------------------------------------------------------------------
⏷ Show the Full List of 26 DME(s)
This Disease Is Related to 397 DOT Molecule(s)
Gene Name DOT ID Evidence Level Mode of Inheritance REF
ACP1 OTJ9CKLU Limited Genetic Variation [28]
ACSBG2 OTRPANSO Limited Biomarker [284]
AGA OTNWT1WB Limited Genetic Variation [285]
ATAD1 OTJ02XFL Limited Biomarker [286]
ATP2C1 OTQN51T3 Limited Genetic Variation [287]
C1orf52 OT8RQW3W Limited Biomarker [288]
CARD11 OTRCTLYC Limited Genetic Variation [289]
CCL8 OTCTWYN8 Limited Biomarker [290]
CHAMP1 OTBGWU86 Limited Biomarker [291]
CHMP2B OTZA7RJB Limited Genetic Variation [34]
CORO1A OTVAZOHC Limited Biomarker [292]
CTNNBL1 OT6KLHPA Limited Biomarker [293]
CTSW OTXSBXFM Limited Biomarker [294]
DAP OT5YLL7E Limited Biomarker [295]
DMRT1 OT5PU9U1 Limited Genetic Variation [34]
EMC3 OTY2H39E Limited Biomarker [296]
ESD OTUSIBPS Limited Genetic Variation [28]
FASTK OTTHFZMP Limited Genetic Variation [297]
IARS1 OT9WXH5N Limited Biomarker [298]
IFNA17 OTHXRYG3 Limited Genetic Variation [299]
ILVBL OTNRRCGY Limited Biomarker [300]
IRF6 OTKJ44EV Limited Altered Expression [301]
KDM5D OTEKG0KD Limited Genetic Variation [302]
KIF3A OTMUBSSK Limited Biomarker [253]
KLHL2 OT1NG8V7 Limited Biomarker [303]
LCN1 OT8BWXTV Limited Biomarker [304]
LRRC4 OT7XJ70N Limited Biomarker [288]
MAFB OTH2N3T8 Limited Genetic Variation [305]
MCCC1 OTLOHEQE Limited Genetic Variation [306]
MNAT1 OTXLOYCB Limited Biomarker [307]
MOV10L1 OTP978LK Limited Biomarker [291]
NFKBIL1 OTYFTPS0 Limited Genetic Variation [308]
NLRP11 OTAL4ADW Limited Altered Expression [309]
NLRP12 OTGR132Z Limited Altered Expression [309]
NT5C3A OT67KZJA Limited Biomarker [307]
OR10A4 OTYYB8SY Limited Biomarker [310]
PACRG OT1NYNNW Limited Genetic Variation [311]
PRF1 OTFVXD7H Limited Genetic Variation [312]
PSME1 OTDHLJWH Limited Biomarker [313]
RHBDL2 OTJPJ8N6 Limited Biomarker [314]
SALL1 OTYYZGLH Limited Biomarker [315]
SEMA4A OT8901H3 Limited Biomarker [316]
SIL1 OTDI85I5 Limited Biomarker [317]
SLAMF1 OTBTT3ZQ Limited Biomarker [318]
SPEN OT37A2MD Limited Biomarker [319]
TOR1B OTNEL2PZ Limited Genetic Variation [320]
TRIM63 OTUSWA74 Limited Biomarker [321]
ADAMTS3 OT2U6VF5 Disputed Altered Expression [38]
ATG10 OTVRPC5X Disputed Genetic Variation [322]
BAG6 OT4Z0S2U Disputed Biomarker [323]
CCNT1 OTDYVGCP Disputed Altered Expression [324]
CCNY OTK1KG5W Disputed Altered Expression [325]
DEFB104A OTLQZR6K Disputed Altered Expression [108]
EMP2 OTPS2H0L Disputed Biomarker [43]
FGFBP2 OT3NBPQO Disputed Biomarker [326]
IFITM3 OT2QP8D3 Disputed Genetic Variation [327]
IL10RA OTOX3D1D Disputed Genetic Variation [328]
MYBBP1A OTIVEMIU Disputed Biomarker [329]
PFKM OT1QY9JM Disputed Biomarker [330]
PNN OT0HXICH Disputed Biomarker [331]
PPBP OT1FHGQS Disputed Biomarker [332]
PROCR OTRHED17 Disputed Altered Expression [47]
PTPRA OTZA82J1 Disputed Biomarker [333]
RPS4X OTIH80EK Disputed Biomarker [334]
SEC14L1 OTA75FET Disputed Genetic Variation [335]
SERPINB9 OTJ811IF Disputed Altered Expression [336]
SMR3B OTL5HNM8 Disputed Biomarker [48]
SPTAN1 OT6VY3A3 Disputed Altered Expression [337]
SRPX OT5B9LXS Disputed Biomarker [331]
TENT5A OTSYF511 Disputed Altered Expression [323]
TMEM72 OT6V5TCP Disputed Biomarker [326]
TMSB15A OTSBWCES Disputed Biomarker [338]
AHSA1 OTC7AFHT moderate Biomarker [50]
GRAP2 OTS5NIZ3 moderate Biomarker [50]
GSTK1 OTDNGWAF moderate Biomarker [254]
KIR3DL1 OTPOSXFX moderate Biomarker [55]
MARCO OT0NW2Q0 moderate Genetic Variation [339]
MT1E OTXJKU4Y moderate Biomarker [340]
NRSN1 OT1KKXC8 moderate Biomarker [53]
POLDIP2 OT8SZSJ6 moderate Biomarker [50]
RNF19A OTKWCV80 moderate Biomarker [50]
THEMIS OTXODBXJ moderate Biomarker [227]
TMED2 OTBLO7RW moderate Biomarker [53]
ACACA OT5CQPZY Strong Biomarker [341]
ACAD8 OT3JI5GB Strong Biomarker [342]
ADAM11 OTPTVW5W Strong Altered Expression [80]
ADGRV1 OTLVXHHP Strong Genetic Variation [343]
AIM2 OT86QUI8 Strong Genetic Variation [344]
AKAP13 OTOZAR14 Strong Biomarker [345]
AMBP OTLU8GU8 Strong Biomarker [127]
ANO9 OTQ2UM3M Strong Genetic Variation [346]
ANP32B OT3SQMLU Strong Altered Expression [347]
ARHGEF2 OTBQTFRT Strong Biomarker [348]
ARHGEF5 OTUVGFT9 Strong Biomarker [349]
ARID1B OTILK3Q7 Strong Genetic Variation [350]
ARMH1 OTTJC0D6 Strong Altered Expression [157]
ART1 OT7FBG5W Strong Biomarker [351]
ASL OTI2NGQR Strong Biomarker [352]
ASPG OT5E2EKR Strong Biomarker [353]
ATG16L1 OTEOYC5D Strong Biomarker [354]
ATG3 OT28VBVK Strong Altered Expression [355]
BATF OT9VSD2D Strong Altered Expression [356]
BATF2 OT4XBZC9 Strong Biomarker [357]
BCL2L10 OTYXQJ3I Strong Biomarker [358]
BCS1L OT5PY5CY Strong Biomarker [359]
BMS1 OTEGQ8ZO Strong Biomarker [341]
BST1 OTAV5SE7 Strong Altered Expression [360]
BTNL2 OTTTEMZA Strong Biomarker [361]
C5AR2 OTP1Q82J Strong Biomarker [362]
CABIN1 OT4G5CIK Strong Biomarker [363]
CARD8 OTXXZYWU Strong Genetic Variation [364]
CARD9 OTJ81AWD Strong Biomarker [365]
CAVIN2 OTFHHDRU Strong Biomarker [215]
CBLIF OTNE20WU Strong Biomarker [366]
CBR4 OT43V4UN Strong Biomarker [367]
CCL1 OT23NON8 Strong Genetic Variation [368]
CCL3L1 OTQXCYB1 Strong Genetic Variation [81]
CCL4 OT6B8P25 Strong Biomarker [369]
CCL4L2 OTDBSXOU Strong Biomarker [369]
CD180 OTITK5E6 Strong Biomarker [370]
CD1B OT4D5EG7 Strong Biomarker [371]
CD244 OTSMR85N Strong Altered Expression [372]
CD48 OT83ZNPP Strong Biomarker [373]
CD53 OT9U5OXJ Strong Altered Expression [374]
CDK15 OT8S67QS Strong Biomarker [164]
CDK16 OTUBXIIT Strong Biomarker [164]
CDX2 OTCG4TSY Strong Altered Expression [375]
CFC1 OT5DHGI8 Strong Genetic Variation [376]
CGAS OTJYIXNB Strong Genetic Variation [377]
CHCHD6 OT8F9BHW Strong Biomarker [378]
CHGB OT7SAQT2 Strong Biomarker [379]
CHP1 OTHTXN1A Strong Biomarker [53]
CILK1 OTWOYEYP Strong Biomarker [164]
CISH OT8T5NYL Strong Altered Expression [380]
CLEC4D OTT7X1UC Strong Biomarker [381]
CLEC4E OT7P8ICY Strong Biomarker [382]
CLEC7A OTRTBH27 Strong Biomarker [365]
CLYBL OTXZLTST Strong Biomarker [383]
CMAS OTFQJG3C Strong Biomarker [384]
CMPK2 OTOG90R0 Strong Biomarker [266]
CRYGC OTYSTQWI Strong Biomarker [385]
CSRP3 OTECBJMV Strong Biomarker [386]
CTNND1 OTUMPSHR Strong Biomarker [99]
CTSZ OTSCX2LL Strong Genetic Variation [387]
CYRIB OTLRN4L1 Strong Biomarker [388]
DARS1 OT0WGC2T Strong Biomarker [389]
DARS2 OTVPFTBG Strong Biomarker [389]
DBP OTE0W7LN Strong Biomarker [390]
DEFB1 OT5SV0E4 Strong Biomarker [391]
DEFB103B OT8RWY64 Strong Altered Expression [392]
DHX9 OT5AAOQI Strong Genetic Variation [393]
DRAM2 OTBOCZH8 Strong Biomarker [394]
DSPP OT1TYNDN Strong Biomarker [395]
DST OTHZBM4X Strong Genetic Variation [396]
DUOX1 OTQ2AEW0 Strong Genetic Variation [397]
DUOX2 OTU14HCN Strong Genetic Variation [397]
EBNA1BP2 OTBRVMZH Strong Altered Expression [157]
EBPL OT59J1GY Strong Biomarker [110]
EEF1A1 OT00THXS Strong Biomarker [398]
EHHADH OTBAAHL5 Strong Biomarker [399]
EMB OT67E3Q1 Strong Genetic Variation [400]
EXTL3 OT2BRUBN Strong Biomarker [401]
FANCC OTTIDM3P Strong Biomarker [402]
FANCD2 OTVEB5LF Strong Biomarker [403]
FCGR2C OTNLMNYB Strong Biomarker [114]
FCGR3B OTSLSPZG Strong Altered Expression [404]
FCN2 OTTHJBKZ Strong Biomarker [405]
FLNB OTPCOYL6 Strong Genetic Variation [192]
GBP5 OTS4AO4A Strong Biomarker [357]
GEMIN4 OTX7402E Strong Genetic Variation [406]
GK OTK2YRA0 Strong Genetic Variation [407]
GNLY OTZJKA8C Strong Biomarker [408]
GZMA OT43R33L Strong Altered Expression [409]
H2BC1 OTNVTJAQ Strong Genetic Variation [410]
H4C1 OTB71W46 Strong Biomarker [153]
HCST OTILCB4K Strong Biomarker [411]
HILPDA OTEID3ZM Strong Biomarker [412]
HIP1 OT7AKCFQ Strong Biomarker [413]
HLA-C OTV38BUJ Strong Biomarker [190]
HLA-DPA1 OT7OG7Y2 Strong Biomarker [125]
HLA-DRA OT7KZMP2 Strong Biomarker [414]
HLA-DRB3 OT5PM9N7 Strong Genetic Variation [195]
HLA-E OTX1CTFB Strong Biomarker [415]
HLCS OTPDUX30 Strong Biomarker [416]
HPX OT14T7Q1 Strong Biomarker [417]
HSD17B6 OTSB55D2 Strong Biomarker [215]
HSD17B8 OTX1DWEF Strong Biomarker [418]
HSPA14 OTZCA5LK Strong Biomarker [419]
HSPA4 OT5HR0AR Strong Biomarker [420]
ICAM3 OTTZ5A5D Strong Biomarker [421]
IFI16 OT4SPU0U Strong Genetic Variation [344]
IFT122 OTSK3OAD Strong Biomarker [422]
IL17B OTS86H50 Strong Biomarker [135]
IL17RA OTVVI8ER Strong Biomarker [423]
IL18BP OTW0LRYZ Strong Biomarker [424]
IL18R1 OT83XMPQ Strong Genetic Variation [425]
IL27 OTIS3OF8 Strong Biomarker [59]
IL27RA OTSQBAKI Strong Biomarker [59]
INHA OT7HWCO3 Strong Genetic Variation [426]
INO80B OTSHV8JF Strong Altered Expression [74]
INSRR OT3F75WA Strong Genetic Variation [427]
IRF7 OTC1A2PQ Strong Genetic Variation [344]
ISG20 OTCWRJJW Strong Biomarker [428]
ITGAX OTOGIMHE Strong Biomarker [429]
KIDINS220 OTLBH2MA Strong Biomarker [430]
KLF2 OTIP1UFX Strong Biomarker [431]
KLHDC2 OTBHH882 Strong Genetic Variation [432]
KLK12 OTNYK59J Strong Biomarker [433]
KLRB1 OTQ2959Y Strong Altered Expression [434]
KLRC2 OTT4N86S Strong Biomarker [149]
KLRF1 OTGHZ7FU Strong Biomarker [149]
LARS1 OT4557NF Strong Biomarker [274]
LBR OT1HG3HG Strong Genetic Variation [435]
LGALS9 OT7MF91K Strong Biomarker [436]
LIN9 OTLHW00C Strong Genetic Variation [437]
MAFK OTZJUE4P Strong Genetic Variation [438]
MAP3K7CL OT9J7RLC Strong Biomarker [439]
MARCHF5 OTBK6BBM Strong Genetic Variation [440]
MASP1 OTWWCNZP Strong Altered Expression [441]
MATN3 OTH9H74J Strong Biomarker [422]
MDP1 OTLUZISP Strong Altered Expression [442]
MFN2 OTPYN8A3 Strong Biomarker [195]
MICA OTPEIEAR Strong Biomarker [443]
MICB OTS2DVDW Strong Genetic Variation [443]
MIP OTEBLU3E Strong Biomarker [444]
MLKL OTDSLC81 Strong Posttranslational Modification [445]
MOXD1 OTUMCWRN Strong Biomarker [446]
MR1 OTZU3XX7 Strong Genetic Variation [447]
MRGPRF OT74OZ2Z Strong Biomarker [221]
MSX2 OT1WDKE1 Strong Biomarker [448]
MTG1 OTC9U1LI Strong Biomarker [449]
MYDGF OT9HRPL6 Strong Biomarker [59]
NAF1 OTMJKJAK Strong Genetic Variation [450]
NCF2 OTAUW7L2 Strong Genetic Variation [397]
NCKIPSD OT24UORN Strong Biomarker [451]
NDUFAB1 OTF906UR Strong Biomarker [452]
NDUFS4 OTJKUYEE Strong Biomarker [453]
NEBL OT2WH1NC Strong Genetic Variation [454]
NLN OTFRITPU Strong Biomarker [455]
NLRC3 OTWLLFFN Strong Biomarker [456]
NLRC4 OTAIA3NA Strong Genetic Variation [457]
NMI OTYVG3NM Strong Biomarker [458]
NTM OTHF0UQU Strong Genetic Variation [459]
NXF1 OTEFHXG6 Strong Genetic Variation [192]
OAS1 OT8ZLOCY Strong Genetic Variation [460]
OASL OTZ05YRP Strong Biomarker [147]
OPN4 OT1LZ7TS Strong Biomarker [455]
OPTN OT2UXWH9 Strong Biomarker [461]
P4HB OTTYNYPF Strong Biomarker [462]
PAGR1 OTXR5PQ8 Strong Biomarker [118]
PARP9 OT7K4494 Strong Biomarker [92]
PC OT6O0V51 Strong Biomarker [463]
PDE6B OTOJMB1V Strong Biomarker [464]
PENK OT8P3HMP Strong Biomarker [121]
PHB2 OTCAX3AW Strong Biomarker [465]
PIP OTH719AH Strong Biomarker [466]
PKP3 OTPL1HRB Strong Genetic Variation [346]
PLA2G10 OTRZ2L5A Strong Biomarker [185]
PLAAT1 OTM3M6P4 Strong Genetic Variation [467]
PMPCA OT5X1G9Q Strong Biomarker [212]
POTEF OTV3WXYE Strong Biomarker [354]
PRKACG OTKOQYF8 Strong Biomarker [164]
PRPF31 OTSJ0Z1Y Strong Genetic Variation [468]
PRPH2 OTNH2G5H Strong Biomarker [469]
PSMD7 OT7PZZ4K Strong Altered Expression [157]
PTBP2 OTF4S7NE Strong Biomarker [193]
PTPN22 OTDCNTC3 Strong Genetic Variation [470]
PYHIN1 OT30GD05 Strong Genetic Variation [344]
RAB27A OT9SQRWY Strong Biomarker [471]
RAB33A OTHHU6WA Strong Biomarker [335]
RABEPK OTCZSREH Strong Altered Expression [157]
RBFOX2 OTXY1WVH Strong Biomarker [221]
RBKS OTDG01Y9 Strong Biomarker [472]
RNASE7 OTIXO0Z4 Strong Biomarker [185]
RNASEH1 OTT7L25X Strong Biomarker [473]
RPS7 OTIK25WI Strong Biomarker [474]
RTL1 OTOT33IM Strong Biomarker [475]
SARDH OTQ49Q27 Strong Altered Expression [180]
SARS1 OTFKXQ1O Strong Biomarker [476]
SARS2 OTU4T99W Strong Biomarker [476]
SCARF1 OT25OJDU Strong Biomarker [357]
SCG2 OTXWUQQL Strong Genetic Variation [477]
SDS OT5WTJ2M Strong Biomarker [478]
SEC14L2 OTJST64D Strong Genetic Variation [192]
SEC14L3 OTGQ8GWM Strong Biomarker [479]
SETMAR OTE2MIMZ Strong Biomarker [475]
SETX OTG3JNOQ Strong Biomarker [212]
SFTPA1 OT87XL1U Strong Genetic Variation [480]
SFTPA2 OT6SFOMU Strong Genetic Variation [480]
SH2D1A OTLU49I5 Strong Altered Expression [481]
SIGIRR OTNC3XFD Strong Genetic Variation [346]
SIGLEC1 OTNWSQA9 Strong Biomarker [482]
SIT1 OT7MDF09 Strong Biomarker [483]
SLN OTERIU75 Strong Biomarker [484]
SMARCAD1 OT90AZTX Strong Biomarker [485]
SMG1 OTTS3SXE Strong Genetic Variation [91]
SMG7 OTZDB0JX Strong Genetic Variation [397]
SMIM10L2B OT04IG2N Strong Biomarker [486]
SMS OT8JYKNH Strong Biomarker [487]
SMURF1 OT5UIZR8 Strong Biomarker [488]
SNRNP70 OTP52YZ3 Strong Biomarker [489]
SOCS2 OTBPNKJQ Strong Altered Expression [490]
SOCS5 OTN1ABYR Strong Altered Expression [490]
SRL OT7IEBWZ Strong Altered Expression [180]
SRSF1 OTF61HOV Strong Altered Expression [491]
SRSF3 OTOFT707 Strong Altered Expression [491]
STING1 OTDAP4G0 Strong Biomarker [130]
STN1 OT8UWRA3 Strong Genetic Variation [450]
SUCLA2 OTMZD4PW Strong Genetic Variation [492]
SUGCT OTA8L0TN Strong Biomarker [493]
SYNM OTOI8TRJ Strong Biomarker [494]
TAP2 OTWSYFI7 Strong Biomarker [479]
TAT OT2CJ91O Strong Biomarker [495]
TBATA OTGDMAAL Strong Genetic Variation [496]
TBC1D1 OTI9V7B0 Strong Genetic Variation [288]
TCOF1 OT4BOYTM Strong Biomarker [422]
TGS1 OTM79LML Strong Genetic Variation [437]
TICAM2 OTK7GIJ5 Strong Genetic Variation [497]
TIMELESS OTD8DCBJ Strong Biomarker [349]
TIMM23 OTAAS85T Strong Genetic Variation [354]
TJP2 OTQUY6BV Strong Biomarker [498]
TLK1 OTICTXI8 Strong Biomarker [164]
TLR10 OTQ1KVJO Strong Biomarker [499]
TMED9 OTYGAQS0 Strong Biomarker [89]
TNFSF8 OTDYGDJ3 Strong Biomarker [500]
TOLLIP OTYEO4NR Strong Genetic Variation [501]
TPI1 OT14KP4B Strong Biomarker [349]
TPPP OTCFMSUF Strong Biomarker [89]
TRAT1 OTMPUNPD Strong Biomarker [502]
TRIM16 OTLRXYOZ Strong Biomarker [503]
TRIM22 OTJBLG5R Strong Altered Expression [504]
TRIM4 OTLKQNKQ Strong Biomarker [502]
TRIT1 OTCU9FS5 Strong Biomarker [505]
TRMT5 OTOAZBPD Strong Genetic Variation [440]
ACOT7 OT7C68YV Definitive Genetic Variation [506]
ACTBL2 OTD6B81U Definitive Genetic Variation [506]
AGBL2 OTCX9987 Definitive Genetic Variation [507]
ARTN OTWIWGL6 Definitive Biomarker [221]
ATG4C OTD9HN3X Definitive Genetic Variation [236]
C2CD2 OTL1K0OB Definitive Genetic Variation [239]
CAP1 OTYM8A2N Definitive Biomarker [508]
CCL19 OTQ2UJMH Definitive Altered Expression [509]
CD1C OT4XINUJ Definitive Biomarker [510]
CD8A OTDWQJXK Definitive Altered Expression [509]
CLEC4M OT2WUIIP Definitive Genetic Variation [421]
CYBA OT16N9ZO Definitive Genetic Variation [511]
DCTN3 OTQOSUES Definitive Biomarker [465]
DMTN OTDTKPBW Definitive Biomarker [512]
DPAGT1 OTYEJAGZ Definitive Biomarker [513]
DUSP14 OTGODFCR Definitive Biomarker [514]
DYNC1H1 OTD1KRKO Definitive Biomarker [465]
DYNC2H1 OTLC8K6B Definitive Genetic Variation [239]
ELF3 OTUTLEQO Definitive Biomarker [515]
ESX1 OTZUPU2C Definitive Biomarker [516]
FCN3 OTPRENLS Definitive Genetic Variation [405]
FHL5 OT6C00Z1 Definitive Genetic Variation [506]
FOXP2 OTVX6A59 Definitive Altered Expression [517]
GAB1 OTQKE6V4 Definitive Altered Expression [235]
GAB2 OTBFN705 Definitive Biomarker [235]
GCNT2 OTRUIMC4 Definitive Biomarker [234]
GNA12 OT3IRZH3 Definitive Genetic Variation [64]
HACD1 OTEC7EP7 Definitive Biomarker [508]
HLA-DQB1 OTVVI3UI Definitive Biomarker [125]
HLA-DRB5 OTUX5TWM Definitive Genetic Variation [195]
HSPA1L OTC2V1K6 Definitive Genetic Variation [518]
ICAM4 OT1BI27E Definitive Biomarker [519]
IFNA1 OTPMKY0L Definitive Altered Expression [77]
IL12RB1 OTM1IJO2 Definitive Biomarker [520]
IL26 OT2WYCW4 Definitive Biomarker [521]
INTS13 OTWE6180 Definitive Biomarker [522]
ITPA OTQ47WVR Definitive Genetic Variation [523]
LAMP3 OTN0XL3W Definitive Biomarker [524]
LSAMP OTYXVQX2 Definitive Biomarker [524]
LYPD4 OTYNO8BS Definitive Biomarker [525]
MAGT1 OTQSAV5C Definitive Biomarker [224]
MARCHF7 OTG9SF10 Definitive Biomarker [526]
MORN2 OTL98XZO Definitive Biomarker [527]
MPG OTAHW80B Definitive Biomarker [528]
NKRF OTUVY0P6 Definitive Altered Expression [529]
NOCT OTVSYP2D Definitive Biomarker [530]
NRG3 OTIFZ5CT Definitive Genetic Variation [236]
NSMAF OTYNVZ23 Definitive Biomarker [268]
POTEM OT7L2HGH Definitive Genetic Variation [506]
PPP1R1A OTGTAGCV Definitive Biomarker [531]
RAB20 OTP9OOVS Definitive Altered Expression [532]
RNF112 OT0Q9OUQ Definitive Biomarker [533]
SEPTIN1 OT4GVSU3 Definitive Biomarker [534]
SERPINB6 OT7G55IK Definitive Biomarker [508]
SFXN1 OTL66767 Definitive Biomarker [535]
SIGLEC14 OT2JGGXD Definitive Genetic Variation [536]
SMUG1 OT2YIOCQ Definitive Biomarker [402]
SORBS1 OTWH8762 Definitive Biomarker [508]
SPAG11A OTNQ9UB0 Definitive Genetic Variation [241]
TBCA OTCCWMGK Definitive Biomarker [537]
TSC1 OTFF4YZ7 Definitive Biomarker [538]
TSC2 OT47LWI9 Definitive Biomarker [538]
TSPAN32 OTSXW7EW Definitive Biomarker [539]
------------------------------------------------------------------------------------
⏷ Show the Full List of 397 DOT(s)

References

1 Novel agents in the management of Mycobacterium tuberculosis disease. Curr Med Chem. 2007;14(18):2000-8.
2 Ethionamide FDA Label
3 Isoniazid FDA Label
4 Moxifloxacin FDA Label
5 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services. 2019
6 Sulfamethoxazole FDA Label
7 Trimethoprim FDA Label
8 ClinicalTrials.gov (NCT01061593) Phase III, Double-blind, Placebo-controlled, Randomized, 1-month Clinical Trial of Immunoxel Combined With Anti-TB Therapy Versus Anti-TB Therapy With Placebo. U.S.National Institutes of Health.
9 ClinicalTrials.gov (NCT05824871) A Multicenter, Randomized, Double-blind, Positive Control Study to Evaluate the Efficacy and Safety of Sudapyridine (WX-081) Tables in Patients With Rifampicin-resistant Pulmonary Tuberculosis. U.S.National Institutes of Health.
10 ClinicalTrials.gov (NCT04044001) A Prospective Phase Ib/IIa, Active-controlled, Randomized, Open-label Study to Evaluate the Safety, Tolerability, Extended Early Bactericidal Activity and Pharmacokinetics of Multiple Oral Doses of BTZ-043 Tablets in Subjects With Newly Diagnosed, Uncomplicated, Smear-positive, Drug-susceptible Pulmonary Tuberculosis. U.S.National Institutes of Health.
11 ClinicalTrials.gov (NCT05473195) A Phase 2 Trial to Evaluate the EBA, Safety and Tolerability of Ethionamide Alone and in Combination With BVL-GSK098 Administered Orally to Adults With Newly Diagnosed, Rifampicin- and Isoniazid-Susceptible Pulmonary Tuberculosis. U.S.National Institutes of Health.
12 ClinicalTrials.gov (NCT03557281) An Early Bactericidal Activity, Safety and Tolerability of GSK3036656 in Subjects With Drug-sensitive Pulmonary Tuberculosis. U.S. National Institutes of Health.
13 ClinicalTrials.gov (NCT03199339) A Phase 1 Study to Evaluate Safety, Tolerability, PK, and PK Interactions of TBA-7371. U.S. National Institutes of Health.
14 ClinicalTrials.gov (NCT03678688) A Phase 1/2 Trial of Multiple Oral Doses of OPC-167832 for Uncomplicated Pulmonary Tuberculosis. U.S. National Institutes of Health.
15 ClinicalTrials.gov (NCT05537038) A Phase Ia, Randomized, Placebo-controlled, Double-blind, Dose-finding Evaluation Trial to Describe the Safety, Reactogenicity, and Immunogenicity of Two Investigational Vaccines Against Tuberculosis in IGRA-negative, BCG na?ve Subjects. U.S.National Institutes of Health.
16 ClinicalTrials.gov (NCT04472897) A Randomised, Double Blind (Sponsor Unblinded), Placebo-controlled, First Time in Human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Repeat Oral Doses and the Food Effect of GSK2556286 in Healthy Adult Participants. U.S.National Institutes of Health.
17 ClinicalTrials.gov (NCT02288481) A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TBA-354 in Healthy Adult Subjects. U.S. National Institutes of Health.
18 ClinicalTrials.gov (NCT04890535) Phase 1, Partially Blinded, Placebo-Controlled, Randomized, Combined Single Ascending Dose With Food Effect Cohort Trial and Multiple Ascending Dose Trial to Evaluate the Safety, Tolerability, and PK of TBAJ-587 in Healthy Adults. U.S.National Institutes of Health.
19 ClinicalTrials.gov (NCT03758612) A Phase 1, Partially-Blinded, Placebo-Controlled, Randomized, Single Ascending Dose (SAD) With a Food Effect Cohort Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TBI-223 in Healthy Adult Participants. U.S.National Institutes of Health.
20 Clinical pipeline report, company report or official report of TB
21 In Vitro and In Vivo Activity of Oxazolidinone Candidate OTB-658 against Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2021 Oct 18;65(11):e0097421.
22 The QcrB Inhibitors TB47 and Telacebec Do Not Potentiate the Activity of Clofazimine in Mycobacterium abscessus. Antimicrob Agents Chemother. 2021 Nov 17;65(12):e0096421.
23 Functional role of the PE domain and immunogenicity of the Mycobacterium tuberculosis triacylglycerol hydrolase LipY.Infect Immun. 2008 Jan;76(1):127-40. doi: 10.1128/IAI.00410-07. Epub 2007 Oct 15.
24 The down-regulation of cathepsin G in THP-1 monocytes after infection with Mycobacterium tuberculosis is associated with increased intracellular survival of bacilli.Infect Immun. 2004 Oct;72(10):5712-21. doi: 10.1128/IAI.72.10.5712-5721.2004.
25 The dUTPase enzyme is essential in Mycobacterium smegmatis.PLoS One. 2012;7(5):e37461. doi: 10.1371/journal.pone.0037461. Epub 2012 May 24.
26 The Apa protein of Mycobacterium tuberculosis stimulates gamma interferon-secreting CD4+ and CD8+ T cells from purified protein derivative-positive individuals and affords protection in a guinea pig model.Infect Immun. 2003 Apr;71(4):1929-37. doi: 10.1128/IAI.71.4.1929-1937.2003.
27 Polymorphisms of N-acetyltransferase 2, glutathione S-transferase mu and theta genes as risk factors of bladder cancer in relation to asthma and tuberculosis.J Urol. 2000 Jul;164(1):209-13.
28 [The use of discrete characters in discriminant analysis for diagnosis of pulmonary tuberculosis and for classification of patients differing in treatment efficiency based on polymorphisms at nine codominant loci-HP, GC, TF, PI, PGM1, GLO1, C3, ACP1 and ESD].Genetika. 2003 Jul;39(7):996-1002.
29 Human leukocyte antigen class I supertypes influence susceptibility and severity of tuberculosis.J Infect Dis. 2004 Mar 1;189(5):805-11. doi: 10.1086/381689. Epub 2004 Feb 16.
30 Study of KIR genes in tuberculosis patients.Tissue Antigens. 2006 Nov;68(5):386-9. doi: 10.1111/j.1399-0039.2006.00685.x.
31 LMP2/LMP7 gene variant: a risk factor for intestinal Mycobacterium tuberculosis infection in the Chinese population.J Gastroenterol Hepatol. 2011 Jul;26(7):1145-50. doi: 10.1111/j.1440-1746.2011.06693.x.
32 Identification of a novel protein antigen encoded by a Mycobacterium tuberculosis-specific RD1 region gene.Scand J Immunol. 1999 May;49(5):515-22. doi: 10.1046/j.1365-3083.1999.00531.x.
33 Analysis of rpsL and rrs mutations in Beijing and non-Beijing streptomycin-resistant Mycobacterium tuberculosis isolates from Singapore.Clin Microbiol Infect. 2010 Mar;16(3):287-9. doi: 10.1111/j.1469-0691.2009.02800.x. Epub 2009 Jun 6.
34 SLC11A1 (NRAMP1) but not SLC11A2 (NRAMP2) polymorphisms are associated with susceptibility to tuberculosis in a high-incidence community in South Africa.Int J Tuberc Lung Dis. 2004 Dec;8(12):1464-71.
35 Diagnosis of human sleeping sickness: sense and sensitivity.Trends Parasitol. 2011 Sep;27(9):394-402. doi: 10.1016/j.pt.2011.04.005. Epub 2011 Jun 12.
36 Fine mapping of a putative tuberculosis-susceptibility locus on chromosome 15q11-13 in African families.Hum Mol Genet. 2002 Jul 1;11(14):1599-603. doi: 10.1093/hmg/11.14.1599.
37 Association of NRAMP 1 gene polymorphism with susceptibility to tuberculosis in Taiwanese aboriginals.J Formos Med Assoc. 2006 May;105(5):363-9. doi: 10.1016/S0929-6646(09)60131-5.
38 Transcript levels of major MMPs and ADAMTS-4 in relation to the clinicopathological profile of patients with tuberculous intervertebral discs and healthy controls.Clin Biochem. 2013 May;46(7-8):603-11. doi: 10.1016/j.clinbiochem.2013.02.006. Epub 2013 Feb 26.
39 Host cell-induced components of the sulfate assimilation pathway are major protective antigens of Mycobacterium tuberculosis.J Infect Dis. 2013 Mar 1;207(5):778-85. doi: 10.1093/infdis/jis751. Epub 2012 Dec 7.
40 Hypothesis: Cystic fibrosis carrier geography reflects interactions of tuberculosis and hypertension with vitamin D deficiency, altitude and temperature. Vitamin D deficiency effects and CF carrier advantage.J Cyst Fibros. 2012 Jan;11(1):68-70. doi: 10.1016/j.jcf.2011.09.007. Epub 2011 Oct 2.
41 A polymorphism in human CD1A is associated with susceptibility to tuberculosis.Genes Immun. 2014 Apr-May;15(3):195-8. doi: 10.1038/gene.2014.5. Epub 2014 Feb 6.
42 Plasmacytoid dendritic cells infiltrate the skin in positive tuberculin skin test indurations.J Invest Dermatol. 2012 Jan;132(1):114-23. doi: 10.1038/jid.2011.246. Epub 2011 Aug 18.
43 Biochemical characterization of recombinant guaA-encoded guanosine monophosphate synthetase (EC 6.3.5.2) from Mycobacterium tuberculosis H37Rv strain.Arch Biochem Biophys. 2012 Jan 1;517(1):1-11. doi: 10.1016/j.abb.2011.11.013. Epub 2011 Nov 18.
44 Gamma interferon receptor defect presenting as recurrent tuberculosis.Indian J Pediatr. 2014 Jul;81(7):696-8. doi: 10.1007/s12098-013-1060-5. Epub 2013 May 17.
45 Induction of protective immunity against Mycobacterium tuberculosis by delivery of ESX antigens into airway dendritic cells.Mucosal Immunol. 2013 May;6(3):522-34. doi: 10.1038/mi.2012.92. Epub 2012 Oct 3.
46 Genetic variants of MARCO are associated with susceptibility to pulmonary tuberculosis in a Gambian population.BMC Med Genet. 2013 Apr 23;14:47. doi: 10.1186/1471-2350-14-47.
47 The endothelial protein C receptor and activated protein C play a limited role in host defense during experimental tuberculosis.Thromb Haemost. 2013 Apr;109(4):726-37. doi: 10.1160/TH12-11-0859. Epub 2013 Jan 24.
48 Suppression of breast tumor growth by DNA vaccination against phosphatase of regenerating liver 3.Gene Ther. 2013 Aug;20(8):834-45. doi: 10.1038/gt.2013.5. Epub 2013 Jan 31.
49 Polymorphisms in the gene that encodes the iron transport protein ferroportin 1 influence susceptibility to tuberculosis.J Infect Dis. 2012 Apr 1;205(7):1043-7. doi: 10.1093/infdis/jis026. Epub 2012 Feb 21.
50 A novel MtHSP70-FPR1 fusion protein enhances cytotoxic T lymphocyte responses to cervical cancer cells by activating human monocyte-derived dendritic cells via the p38 MAPK signaling pathway.Biochem Biophys Res Commun. 2018 Sep 10;503(3):2108-2116. doi: 10.1016/j.bbrc.2018.07.167. Epub 2018 Aug 8.
51 Circulating HLA-DR+CD4+ effector memory T cells resistant to CCR5 and PD-L1 mediated suppression compromise regulatory T cell function in tuberculosis.PLoS Pathog. 2018 Sep 19;14(9):e1007289. doi: 10.1371/journal.ppat.1007289. eCollection 2018 Sep.
52 Differential expression and predictive value of monocyte scavenger receptor CD163 in populations with different tuberculosis infection statuses.BMC Infect Dis. 2019 Nov 28;19(1):1006. doi: 10.1186/s12879-019-4525-y.
53 HIV-associated benign lymphoepithelial cysts of the parotid glands confirmed by HIV-1 p24 antigen immunostaining.BMJ Case Rep. 2017 Sep 28;2017:bcr2017221869. doi: 10.1136/bcr-2017-221869.
54 Genetic polymorphism in association with susceptibility to tuberculosis: a study in a Pakistani population.Braz J Microbiol. 2019 Apr;50(2):429-434. doi: 10.1007/s42770-019-00048-8. Epub 2019 Feb 25.
55 Activating KIRs alter susceptibility to pulmonary tuberculosis in a South African population.Tuberculosis (Edinb). 2015 Dec;95(6):817-821. doi: 10.1016/j.tube.2015.09.003. Epub 2015 Oct 17.
56 Hepcidin exerts a negative immunological effect in pulmonary tuberculosis without HIV co-infection, prolonging the time to culture-negative.Int J Infect Dis. 2019 Sep;86:47-54. doi: 10.1016/j.ijid.2019.06.023. Epub 2019 Jun 25.
57 Mechanism of HrcA function in heat shock regulation in Mycobacterium tuberculosis.Biochimie. 2020 Jan;168:285-296. doi: 10.1016/j.biochi.2019.11.012. Epub 2019 Nov 22.
58 Transcriptional landscape of Mycobacterium tuberculosis infection in macrophages.Sci Rep. 2018 Apr 30;8(1):6758. doi: 10.1038/s41598-018-24509-6.
59 The increased protection and pathology in Mycobacterium tuberculosis-infected IL-27R-alpha-deficient mice is supported by IL-17A and is associated with the IL-17A-induced expansion of multifunctional T cells.Mucosal Immunol. 2018 Jul;11(4):1168-1180. doi: 10.1038/s41385-018-0026-3. Epub 2018 May 4.
60 IL-32 and its splice variants are associated with protection againstMycobacterium tuberculosis infectionand skewing of Th1/Th17 cytokines.J Leukoc Biol. 2020 Jan;107(1):113-118. doi: 10.1002/JLB.4AB0219-071R. Epub 2019 Aug 4.
61 Interferon regulatory factor 1 eliminates mycobacteria by suppressing p70 S6 kinase via mechanistic target of rapamycin signaling.J Infect. 2019 Sep;79(3):262-276. doi: 10.1016/j.jinf.2019.06.007. Epub 2019 Jun 18.
62 Tuberculosis, onychomycosis and immune deficiency in complicated Crohn's disease.BMJ Case Rep. 2019 Aug 4;12(8):e228986. doi: 10.1136/bcr-2018-228986.
63 Association of the TLR1 variant rs5743557 with susceptibility to tuberculosis.J Thorac Dis. 2019 Feb;11(2):583-594. doi: 10.21037/jtd.2019.01.74.
64 Molecular profiling of drug resistant isolates of Mycobacterium tuberculosis in the state of Santa Catarina, southern Brazil.Mem Inst Oswaldo Cruz. 2015 Aug;110(5):618-23. doi: 10.1590/0074-02760150100. Epub 2015 Jul 7.
65 ACR Appropriateness Criteria() Imaging ofPossible Tuberculosis.J Am Coll Radiol. 2017 May;14(5S):S160-S165. doi: 10.1016/j.jacr.2017.02.022.
66 Serum concentrations of A disintegrin and metalloproteinase 9 (ADAM9) mRNA as a promising novel marker for the detection of pulmonary sarcoidosis.J Int Med Res. 2013 Aug;41(4):1236-41. doi: 10.1177/0300060513489471. Epub 2013 Jul 15.
67 Cordycepin kills Mycobacterium tuberculosis through hijacking the bacterial adenosine kinase.PLoS One. 2019 Jun 14;14(6):e0218449. doi: 10.1371/journal.pone.0218449. eCollection 2019.
68 CD4+ T cell cytokine responses to the DAR-901 booster vaccine in BCG-primed adults: A randomized, placebo-controlled trial.PLoS One. 2019 May 23;14(5):e0217091. doi: 10.1371/journal.pone.0217091. eCollection 2019.
69 [Polymorphism of genes of the renin-angiotensin system ACE, AT1R, and AT2R in patients with pulmonary tuberculosis].Mol Gen Mikrobiol Virusol. 2008;(2):12-8.
70 Time-Dependent Changes in Urinary Metabolome Before and After Intensive Phase Tuberculosis Therapy: A Pharmacometabolomics Study.OMICS. 2019 Nov;23(11):560-572. doi: 10.1089/omi.2019.0140. Epub 2019 Oct 15.
71 PPAR is critical for Mycobacterium tuberculosis induction of Mcl-1 and limitation of human macrophage apoptosis.PLoS Pathog. 2018 Jun 21;14(6):e1007100. doi: 10.1371/journal.ppat.1007100. eCollection 2018 Jun.
72 Preparation and characterization of the antibody recognizing AMACR inside its catalytic center.Int J Oncol. 2018 Feb;52(2):547-559. doi: 10.3892/ijo.2017.4220. Epub 2017 Dec 11.
73 Molecular modeling studies to explore the binding affinity of virtually screened inhibitor toward different aminoglycoside kinases from diverse MDR strains.J Cell Biochem. 2018 Mar;119(3):2679-2695. doi: 10.1002/jcb.26435. Epub 2017 Dec 4.
74 Genome-wide DNA methylation and transcriptome and proteome changes in Mycobacterium tuberculosis with para-aminosalicylic acid resistance.Chem Biol Drug Des. 2020 Jan;95(1):104-112. doi: 10.1111/cbdd.13625. Epub 2019 Nov 7.
75 Secondary metabolites from Triclisia gilletii (De Wild) Staner (Menispermaceae) with antimycobacterial activity against Mycobacterium tuberculosis.Nat Prod Res. 2019 Mar;33(5):642-650. doi: 10.1080/14786419.2017.1402324. Epub 2017 Nov 16.
76 The association between BACH1 polymorphisms and anti-tuberculosis drug-induced hepatotoxicity in a Chinese cohort.Infect Genet Evol. 2018 Dec;66:217-221. doi: 10.1016/j.meegid.2018.10.006. Epub 2018 Oct 11.
77 HIV Infection Is Associated With Downregulation of BTLA Expression on Mycobacterium tuberculosis-Specific CD4 T Cells in Active Tuberculosis Disease.Front Immunol. 2019 Aug 21;10:1983. doi: 10.3389/fimmu.2019.01983. eCollection 2019.
78 Circulating and tumor-associated caspase-4: a novel diagnostic and prognostic biomarker for non-small cell lung cancer.Oncotarget. 2018 Apr 10;9(27):19356-19367. doi: 10.18632/oncotarget.25049. eCollection 2018 Apr 10.
79 CCL20 is overexpressed in Mycobacterium tuberculosis-infected monocytes and inhibits the production of reactive oxygen species (ROS).Clin Exp Immunol. 2010 Nov;162(2):289-97. doi: 10.1111/j.1365-2249.2010.04168.x. Epub 2010 Sep 1.
80 Diagnostic performance of plasma cytokine biosignature combination and MCP-1 as individual biomarkers for differentiating stages Mycobacterium tuberculosis infection.J Infect. 2019 Apr;78(4):281-291. doi: 10.1016/j.jinf.2018.10.017. Epub 2018 Dec 5.
81 CCL3L1 copy number, CCR5 genotype and susceptibility to tuberculosis.BMC Med Genet. 2014 Jan 9;15:5. doi: 10.1186/1471-2350-15-5.
82 A novel role for C-C motif chemokine receptor 2 during infection with hypervirulent Mycobacterium tuberculosis.Mucosal Immunol. 2018 Nov;11(6):1727-1742. doi: 10.1038/s41385-018-0071-y. Epub 2018 Aug 16.
83 Study of CD27 and CCR4 Markers on Specific CD4(+) T-Cells as Immune Tools for Active and Latent Tuberculosis Management.Front Immunol. 2019 Jan 9;9:3094. doi: 10.3389/fimmu.2018.03094. eCollection 2018.
84 Differential expression of CXCR3 and CCR6 on CD4(+) T-lymphocytes with distinct memory phenotypes characterizes tuberculosis-associated immune reconstitution inflammatory syndrome.Sci Rep. 2019 Feb 6;9(1):1502. doi: 10.1038/s41598-018-37846-3.
85 CD27 expression of T-cells discriminates IGRA-negative TB patients from healthy contacts in Ghana.Microbes Infect. 2020 Jan-Feb;22(1):65-68. doi: 10.1016/j.micinf.2019.07.003. Epub 2019 Aug 12.
86 High expression of BTLA and B7-H4 on the surface of myeloid dendritic cells has a negative regulatory effect on their anti-tuberculosis immunity activity in pleural tuberculosis patients.Tuberculosis (Edinb). 2019 Dec;119:101877. doi: 10.1016/j.tube.2019.101877. Epub 2019 Oct 11.
87 Blood tolerogenic monocytes and low proportions of dendritic cell subpopulations are hallmarks of human tuberculosis.J Leukoc Biol. 2018 May;103(5):945-954. doi: 10.1002/JLB.4A1117-448R. Epub 2018 Feb 28.
88 Collaborative drug discovery for More Medicines for Tuberculosis (MM4TB).Drug Discov Today. 2017 Mar;22(3):555-565. doi: 10.1016/j.drudis.2016.10.009. Epub 2016 Nov 22.
89 Sequential pulmonary immunization with heterologous recombinant influenza A virus tuberculosis vaccines protects against murine M. tuberculosis infection.Vaccine. 2018 Apr 25;36(18):2462-2470. doi: 10.1016/j.vaccine.2018.03.037. Epub 2018 Mar 27.
90 An evolutionary recent IFN/IL-6/CEBP axis is linked to monocyte expansion and tuberculosis severity in humans.Elife. 2019 Oct 22;8:e47013. doi: 10.7554/eLife.47013.
91 Rv0646c, an esterase from M. tuberculosis, up-regulates the host immune response in THP-1 macrophages cells.Mol Cell Biochem. 2018 Oct;447(1-2):189-202. doi: 10.1007/s11010-018-3303-2. Epub 2018 Jan 31.
92 Platelets Regulate Pulmonary Inflammation and Tissue Destruction in Tuberculosis.Am J Respir Crit Care Med. 2018 Jul 15;198(2):245-255. doi: 10.1164/rccm.201710-2102OC.
93 The BCG Moreau RD16 deletion inactivates a repressor reshaping transcription of an adjacent gene.Tuberculosis (Edinb). 2014 Jan;94(1):26-33. doi: 10.1016/j.tube.2013.11.004. Epub 2013 Nov 26.
94 CFD simulations for paper-based DNA amplification reaction (LAMP) of Mycobacterium tuberculosis-point-of-care diagnostic perspective.Med Biol Eng Comput. 2020 Feb;58(2):271-289. doi: 10.1007/s11517-019-02082-y. Epub 2019 Dec 16.
95 Thiol modified chitosan self-assembled monolayer platform for nucleic acid biosensor.Appl Biochem Biotechnol. 2014 Oct;174(3):1201-13. doi: 10.1007/s12010-014-1177-7. Epub 2014 Sep 10.
96 Deciphering the molecular basis of mycobacteria and lipoglycan recognition by the C-type lectin Dectin-2.Sci Rep. 2018 Nov 15;8(1):16840. doi: 10.1038/s41598-018-35393-5.
97 CLEC9A modulates macrophage-mediated neutrophil recruitment in response to heat-killed Mycobacterium tuberculosis H37Ra.PLoS One. 2017 Oct 24;12(10):e0186780. doi: 10.1371/journal.pone.0186780. eCollection 2017.
98 The role of variants from the innate immune system genes in tuberculosis and skin test response in a Native American population.Hum Immunol. 2016 Oct;77(10):981-984. doi: 10.1016/j.humimm.2016.06.017. Epub 2016 Jun 23.
99 Macro-geographical specificities of the prevailing tuberculosis epidemic as seen through SITVIT2, an updated version of the Mycobacterium tuberculosis genotyping database.Infect Genet Evol. 2019 Aug;72:31-43. doi: 10.1016/j.meegid.2018.12.030. Epub 2018 Dec 26.
100 PD-1-expressing MAIT cells from patients with tuberculosis exhibit elevated production of CXCL13.Scand J Immunol. 2020 Apr;91(4):e12858. doi: 10.1111/sji.12858. Epub 2020 Jan 8.
101 Genetic polymorphisms of CCL2 associated with susceptibility to latent tuberculous infection in Thailand.Int J Tuberc Lung Dis. 2016 Sep;20(9):1242-8. doi: 10.5588/ijtld.16.0017.
102 TLR4-NOX2 axis regulates the phagocytosis and killing of Mycobacterium tuberculosis by macrophages.BMC Pulm Med. 2017 Dec 12;17(1):194. doi: 10.1186/s12890-017-0517-0.
103 Lack of association between genetic polymorphisms of CYP3A4, CYP2C9 and CYP2C19 and antituberculosis drug-induced liver injury in a community-based Chinese population.Clin Exp Pharmacol Physiol. 2013 May;40(5):326-32. doi: 10.1111/1440-1681.12074.
104 Determinants of the Inhibition of DprE1 and CYP2C9 by Antitubercular Thiophenes.Angew Chem Int Ed Engl. 2017 Oct 9;56(42):13011-13015. doi: 10.1002/anie.201707324. Epub 2017 Sep 7.
105 Mycobactericidal activity of bedaquiline plus rifabutin or rifampin in ex vivo whole blood cultures of healthy volunteers: A randomized controlled trial.PLoS One. 2018 May 2;13(5):e0196756. doi: 10.1371/journal.pone.0196756. eCollection 2018.
106 Association of the CYP2B6 gene with anti-tuberculosis drug-induced hepatotoxicity in a Brazilian Amazon population.Int J Infect Dis. 2015 Apr;33:28-31. doi: 10.1016/j.ijid.2014.04.011. Epub 2014 Sep 28.
107 Characterization of G-Quadruplex Motifs in espB, espK, and cyp51 Genes of Mycobacterium tuberculosis as Potential Drug Targets.Mol Ther Nucleic Acids. 2019 Jun 7;16:698-706. doi: 10.1016/j.omtn.2019.04.022. Epub 2019 Apr 30.
108 IL-32 is a molecular marker of a host defense network in human tuberculosis.Sci Transl Med. 2014 Aug 20;6(250):250ra114. doi: 10.1126/scitranslmed.3009546.
109 Expansion of a novel lead targeting M. tuberculosis DHFR as antitubercular agents.Bioorg Med Chem. 2019 Apr 1;27(7):1421-1429. doi: 10.1016/j.bmc.2019.02.053. Epub 2019 Feb 26.
110 Interaction of Erp Protein of Mycobacterium tuberculosis with Rv2212 Enhances Intracellular Survival of Mycobacterium smegmatis.J Bacteriol. 2016 Sep 22;198(20):2841-52. doi: 10.1128/JB.00120-16. Print 2016 Oct 15.
111 Eosinophil peroxidase oxidizes isoniazid to form the active metabolite against M. tuberculosis, isoniazid-NAD(). Chem Biol Interact. 2019 May 25;305:48-53. doi: 10.1016/j.cbi.2019.03.019. Epub 2019 Mar 25.
112 Polymorphism in the EREG gene confers susceptibility to tuberculosis.BMC Med Genet. 2019 Jan 11;20(1):7. doi: 10.1186/s12881-018-0729-z.
113 Activity and thermal stability of Mycobacterium tuberculosis PE1 and PE2 proteins esterase domain in the presence of aprotic ionic liquids.Spectrochim Acta A Mol Biomol Spectrosc. 2020 Jan 15;225:117477. doi: 10.1016/j.saa.2019.117477. Epub 2019 Aug 19.
114 Neutrophil CD64, TLR2 and TLR4 expression increases but phagocytic potential decreases during tuberculosis.Tuberculosis (Edinb). 2018 Jul;111:135-142. doi: 10.1016/j.tube.2018.06.010. Epub 2018 Jun 9.
115 Antituberculosis Drug-Induced Adverse Events in the Liver, Kidneys, and Blood: Clinical Profiles and Pharmacogenetic Predictors.Clin Pharmacol Ther. 2018 Aug;104(2):326-334. doi: 10.1002/cpt.924. Epub 2017 Nov 23.
116 Ferritin H Deficiency in Myeloid Compartments Dysregulates Host Energy Metabolism and Increases Susceptibility to Mycobacterium tuberculosis Infection.Front Immunol. 2018 May 3;9:860. doi: 10.3389/fimmu.2018.00860. eCollection 2018.
117 Rv3634c from Mycobacterium tuberculosis H37Rv encodes an enzyme with UDP-Gal/Glc and UDP-GalNAc 4-epimerase activities.PLoS One. 2017 Apr 12;12(4):e0175193. doi: 10.1371/journal.pone.0175193. eCollection 2017.
118 Streptococcal dTDP-L-rhamnose biosynthesis enzymes: functional characterization and lead compound identification.Mol Microbiol. 2019 Apr;111(4):951-964. doi: 10.1111/mmi.14197. Epub 2019 Jan 31.
119 Expression of glyceraldehyde-3-phosphate dehydrogenase from M. tuberculosis in E. coli. Purification and characteristics of the untagged recombinant enzyme.Protein Expr Purif. 2019 May;157:28-35. doi: 10.1016/j.pep.2019.01.010. Epub 2019 Jan 30.
120 Long-term protective efficacy with a BCG-prime ID93/GLA-SE boost regimen against the hyper-virulent Mycobacterium tuberculosis strain K in a mouse model.Sci Rep. 2019 Oct 29;9(1):15560. doi: 10.1038/s41598-019-52146-0.
121 Adjunctive Immunotherapeutic Efficacy of N-Formylated Internal Peptide of Mycobacterial Glutamine Synthetase in Mouse Model of Tuberculosis.Protein Pept Lett. 2020;27(3):236-242. doi: 10.2174/0929866526666191028151615.
122 Granzyme B induced by Rv0140 antigen discriminates latently infected from active tuberculosis individuals.J Leukoc Biol. 2019 Feb;105(2):297-306. doi: 10.1002/JLB.MA0318-117R. Epub 2018 Sep 13.
123 The role of HCN channels in peristaltic dysfunction in human ureteral tuberculosis.Int Urol Nephrol. 2018 Apr;50(4):639-645. doi: 10.1007/s11255-018-1816-y. Epub 2018 Feb 19.
124 Mycobacterium tuberculosis infection induces IL-10 gene expression by disturbing histone deacetylase 6 and histonedeacetylase 11 equilibrium in macrophages.Tuberculosis (Edinb). 2018 Jan;108:118-123. doi: 10.1016/j.tube.2017.11.008. Epub 2017 Nov 21.
125 Association of human leukocyte antigens-DQB2/DPA1/DPB1 polymorphism and pulmonary tuberculosis in the Chinese Uygur population.Mol Genet Genomic Med. 2019 Mar;7(3):e544. doi: 10.1002/mgg3.544. Epub 2019 Jan 1.
126 Clinical value of haptoglobin and soluble CD163 testing for the differential diagnosis of tuberculous and malignant pleural effusions.Medicine (Baltimore). 2019 Oct;98(42):e17416. doi: 10.1097/MD.0000000000017416.
127 Survival of people living with HIV who defaulted from tuberculosis treatment in a cohort, Recife, Brazil.BMC Infect Dis. 2017 Feb 10;17(1):137. doi: 10.1186/s12879-016-2127-5.
128 Distribution of insertion- and deletion-associated genetic polymorphisms among four Mycobacterium tuberculosis phospholipase C genes and associations with extrathoracic tuberculosis: a population-based study.J Clin Microbiol. 2005 Dec;43(12):6048-53. doi: 10.1128/JCM.43.12.6048-6053.2005.
129 The crystal structure of an essential high-temperature requirement protein HtrA1 (Rv1223) from Mycobacterium tuberculosis reveals its unique features.Acta Crystallogr D Struct Biol. 2018 Sep 1;74(Pt 9):906-921. doi: 10.1107/S205979831800952X. Epub 2018 Sep 5.
130 Sterile Lung Inflammation Induced by Silica Exacerbates Mycobacterium tuberculosis Infection via STING-Dependent Type 2 Immunity.Cell Rep. 2019 May 28;27(9):2649-2664.e5. doi: 10.1016/j.celrep.2019.04.110.
131 The immune characterization of interferon- responses in tuberculosis patients.Microbiol Immunol. 2018 Apr;62(4):281-290. doi: 10.1111/1348-0421.12583. Epub 2018 Apr 18.
132 Prevalence, distribution and functional significance of the -237C to T polymorphism in the IL-12R2 promoter in Indian tuberculosis patients.PLoS One. 2012;7(4):e34355. doi: 10.1371/journal.pone.0034355. Epub 2012 Apr 3.
133 Levels of vitamin D-associated cytokines distinguish between active and latent tuberculosis following a tuberculosis outbreak.BMC Infect Dis. 2019 Feb 13;19(1):151. doi: 10.1186/s12879-019-3798-5.
134 IL1R1 and IL1R2 polymorphisms were associated with tuberculosis risk: A pilot study.J Gene Med. 2018 Oct;20(10-11):e3057. doi: 10.1002/jgm.3057. Epub 2018 Oct 18.
135 Modulation of Th1/Tc1 and Th17/Tc17 responses in pulmonary tuberculosis by IL-20 subfamily of cytokines.Cytokine. 2018 Aug;108:190-196. doi: 10.1016/j.cyto.2018.04.005. Epub 2018 Apr 21.
136 Interleukin-21 Regulates Natural Killer Cell Responses During Mycobacterium tuberculosis Infection.J Infect Dis. 2018 Mar 28;217(8):1323-1333. doi: 10.1093/infdis/jiy034.
137 IL-21 Receptor Signaling Is Essential for Optimal CD4(+) T Cell Function and Control of Mycobacterium tuberculosis Infection in Mice.J Immunol. 2017 Oct 15;199(8):2815-2822. doi: 10.4049/jimmunol.1601231. Epub 2017 Aug 30.
138 The variations of IL-23R are associated with susceptibility and severe clinical forms of pulmonary tuberculosis in Chinese Uygurs.BMC Infect Dis. 2015 Dec 1;15:550. doi: 10.1186/s12879-015-1284-2.
139 In vitro levels of cytokines in response to purified protein derivative (PPD) antigen in a population with high prevalence of pulmonary tuberculosis.Hum Immunol. 2010 Nov;71(11):1099-104. doi: 10.1016/j.humimm.2010.07.006. Epub 2010 Aug 2.
140 Killer (FASL regulatory) B cells are present during latent TB and are induced by BCG stimulation in participants with and without latent tuberculosis.Tuberculosis (Edinb). 2018 Jan;108:114-117. doi: 10.1016/j.tube.2017.11.010. Epub 2017 Nov 24.
141 An IL7RA exon 5 polymorphism is associated with impaired IL-7R splicing and protection against tuberculosis in Ghana.Genes Immun. 2019 Jul;20(6):514-519. doi: 10.1038/s41435-018-0049-5. Epub 2018 Oct 31.
142 A chromosome 5q31.1 locus associates with tuberculin skin test reactivity in HIV-positive individuals from tuberculosis hyper-endemic regions in east Africa.PLoS Genet. 2017 Jun 19;13(6):e1006710. doi: 10.1371/journal.pgen.1006710. eCollection 2017 Jun.
143 Expanding Benzoxazole-Based Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitor Structure-Activity As Potential Antituberculosis Agents.J Med Chem. 2018 Jun 14;61(11):4739-4756. doi: 10.1021/acs.jmedchem.7b01839. Epub 2018 May 30.
144 IRAK-M alters the polarity of macrophages to facilitate the survival of Mycobacterium tuberculosis.BMC Microbiol. 2017 Aug 23;17(1):185. doi: 10.1186/s12866-017-1095-2.
145 Defective MyD88 and IRAK4 but not TLR-2 expression in HIV+ individuals with latent tuberculosis infection.Cytokine. 2018 Oct;110:213-221. doi: 10.1016/j.cyto.2018.05.005. Epub 2018 May 17.
146 Interferon regulatory factor 8-deficiency determines massive neutrophil recruitment but T cell defect in fast growing granulomas during tuberculosis.PLoS One. 2013 May 24;8(5):e62751. doi: 10.1371/journal.pone.0062751. Print 2013.
147 Characteristic genes in THP? derived macrophages infected with Mycobacterium tuberculosis H37Rv strain identified by integrating bioinformatics methods.Int J Mol Med. 2019 Oct;44(4):1243-1254. doi: 10.3892/ijmm.2019.4293. Epub 2019 Jul 30.
148 Expression and role of VLA-1 in resident memory CD8 T cell responses to respiratory mucosal viral-vectored immunization against tuberculosis.Sci Rep. 2017 Aug 25;7(1):9525. doi: 10.1038/s41598-017-09909-4.
149 Changes in the NK Cell Repertoire Related to Initiation of TB Treatment and Onset of Immune Reconstitution Inflammatory Syndrome in TB/HIV Co-infected Patients in Rio de Janeiro, Brazil-ANRS 12274.Front Immunol. 2019 Aug 13;10:1800. doi: 10.3389/fimmu.2019.01800. eCollection 2019.
150 Killer cell immunoglobulin like receptor gene association with tuberculosis.Hum Immunol. 2013 Jan;74(1):85-92. doi: 10.1016/j.humimm.2012.10.006. Epub 2012 Oct 13.
151 The Role of KLRG1 in Human CD4+ T-Cell Immunity Against Tuberculosis.J Infect Dis. 2018 Apr 11;217(9):1491-1503. doi: 10.1093/infdis/jiy046.
152 High Activation of T Cells and the 2(pos) T-Cell Subset Is Associated With the Onset of Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome, ANRS 12153 CAPRI NK.Front Immunol. 2019 Aug 27;10:2018. doi: 10.3389/fimmu.2019.02018. eCollection 2019.
153 Histone Methyltransferase SET8 Epigenetically Reprograms Host Immune Responses to Assist Mycobacterial Survival.J Infect Dis. 2017 Aug 15;216(4):477-488. doi: 10.1093/infdis/jix322.
154 Multinomial modelling of TB/HIV co-infection yields a robust predictive signature and generates hypotheses about the HIV+TB+ disease state.PLoS One. 2019 Jul 15;14(7):e0219322. doi: 10.1371/journal.pone.0219322. eCollection 2019.
155 Molecular epidemiology of Mycobacterium tuberculosis strains from prison populations in Santa Catarina, Southern Brazil.Infect Genet Evol. 2018 Mar;58:34-39. doi: 10.1016/j.meegid.2017.12.010. Epub 2017 Dec 15.
156 Invariant Natural Killer T-cell Dynamics in Human Immunodeficiency Virus-associated Tuberculosis.Clin Infect Dis. 2020 Apr 15;70(9):1865-1874. doi: 10.1093/cid/ciz501.
157 Mycobacterium tuberculosis PPE44 (Rv2770c) is involved in response to multiple stresses and promotes the macrophage expression of IL-12 p40 and IL-6 via the p38, ERK, and NF-B signaling axis.Int Immunopharmacol. 2017 Sep;50:319-329. doi: 10.1016/j.intimp.2017.06.028. Epub 2017 Jul 22.
158 Inhibiting HLA-G restores IFN- and TNF- producing T cell in pleural Tuberculosis.Tuberculosis (Edinb). 2018 Mar;109:69-79. doi: 10.1016/j.tube.2018.01.008. Epub 2018 Feb 6.
159 Characterization and function of Mycobacterium tuberculosis H37Rv Lipase Rv1076 (LipU).Microbiol Res. 2017 Mar;196:7-16. doi: 10.1016/j.micres.2016.12.005. Epub 2016 Dec 15.
160 Speeding up the diagnosis of multidrug-resistant tuberculosis in a high-burden region with the use of a commercial line probe assay.J Bras Pneumol. 2019 Apr 18;45(2):e20180128. doi: 10.1590/1806-3713/e20180128.
161 Role of LTA4H Polymorphism in Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome Occurrence and Clinical Severity in Patients Infected with HIV.PLoS One. 2016 Sep 19;11(9):e0163298. doi: 10.1371/journal.pone.0163298. eCollection 2016.
162 M. tuberculosis infection and antigen specific cytokine response in healthcare workers frequently exposed to tuberculosis.Sci Rep. 2019 Jun 3;9(1):8201. doi: 10.1038/s41598-019-44294-0.
163 Synergy between Circular Bacteriocin AS-48 and Ethambutol against Mycobacterium tuberculosis.Antimicrob Agents Chemother. 2018 Aug 27;62(9):e00359-18. doi: 10.1128/AAC.00359-18. Print 2018 Sep.
164 Synthesis and antimycobacterial activity of imidazo[1,2-b][1,2,4,5]tetrazines.Eur J Med Chem. 2019 Sep 15;178:39-47. doi: 10.1016/j.ejmech.2019.05.081. Epub 2019 May 31.
165 Molecular detection of drug resistance to ofloxacin and kanamycin in Mycobacterium tuberculosis by using multiplex allele-specific PCR.J Infect Public Health. 2018 Jan-Feb;11(1):54-58. doi: 10.1016/j.jiph.2017.03.007. Epub 2017 Apr 9.
166 Valproic acid attenuates inflammation of optic nerve and apoptosis of retinal ganglion cells in a rat model of optic neuritis.Biomed Pharmacother. 2017 Dec;96:1363-1370. doi: 10.1016/j.biopha.2017.11.066. Epub 2017 Dec 2.
167 Sphingolipids Are Dual Specific Drug Targets for the Management of Pulmonary Infections: Perspective.Front Immunol. 2017 Mar 29;8:378. doi: 10.3389/fimmu.2017.00378. eCollection 2017.
168 Association analysis of melanocortin 3 receptor polymorphisms with the risk of pulmonary tuberculosis.Lung. 2014 Dec;192(6):857-62. doi: 10.1007/s00408-014-9625-2. Epub 2014 Jul 27.
169 MapB Protein is the Essential Methionine Aminopeptidase in Mycobacterium tuberculosis.Cells. 2019 Apr 28;8(5):393. doi: 10.3390/cells8050393.
170 Macrophage migration inhibitory factor-794 CATT microsatellite polymorphism and risk of tuberculosis: a meta-analysis.Biosci Rep. 2018 Jul 6;38(4):BSR20171626. doi: 10.1042/BSR20171626. Print 2018 Aug 31.
171 Physicochemical, pharmacokinetic, efficacy and toxicity profiling of a potential nitrofuranyl methyl piperazine derivative IIIM-MCD-211 for oral tuberculosis therapy via in-silico-in-vitro-in-vivo approach.Pulm Pharmacol Ther. 2018 Feb;48:151-160. doi: 10.1016/j.pupt.2017.11.006. Epub 2017 Nov 21.
172 Early Secretory Antigenic Target-6 Drives Matrix Metalloproteinase-10 Gene Expression and Secretion in Tuberculosis.Am J Respir Cell Mol Biol. 2017 Feb;56(2):223-232. doi: 10.1165/rcmb.2016-0162OC.
173 Active Induction of Experimental Autoimmune Encephalomyelitis (EAE) with MOG(35-55) in the Mouse.Methods Mol Biol. 2018;1791:227-232. doi: 10.1007/978-1-4939-7862-5_17.
174 Merged experimental guided computational strategy toward tuberculosis treatment mediated by alveolar macrophages mannose receptor.J Biomol Struct Dyn. 2020 Oct;38(17):5195-5203. doi: 10.1080/07391102.2019.1697369. Epub 2019 Dec 20.
175 Application of genome editing in farm animals: cattle.Transgenic Res. 2019 Aug;28(Suppl 2):93-100. doi: 10.1007/s11248-019-00141-6.
176 Plasma cell-free DNA level and its integrity as biomarkers to distinguish non-small cell lung cancer from tuberculosis.Clin Chim Acta. 2018 Feb;477:160-165. doi: 10.1016/j.cca.2017.11.003. Epub 2017 Nov 4.
177 Vimentin expressed on Mycobacterium tuberculosis-infected human monocytes is involved in binding to the NKp46 receptor.J Immunol. 2006 Nov 1;177(9):6192-8. doi: 10.4049/jimmunol.177.9.6192.
178 The E3 ubiquitin ligase NEDD4 enhances killing of membrane-perturbing intracellular bacteria by promoting autophagy.Autophagy. 2017;13(12):2041-2055. doi: 10.1080/15548627.2017.1376160. Epub 2017 Dec 17.
179 A Notch4 missense mutation is associated with susceptibility to tuberculosis in Chinese population.Infect Genet Evol. 2020 Mar;78:104145. doi: 10.1016/j.meegid.2019.104145. Epub 2019 Dec 13.
180 Novel Antimycobacterial Compounds Suppress NAD Biogenesis by Targeting a Unique Pocket of NaMN Adenylyltransferase.ACS Chem Biol. 2019 May 17;14(5):949-958. doi: 10.1021/acschembio.9b00124. Epub 2019 Apr 17.
181 Synergistic Lethality of a Binary Inhibitor of Mycobacterium tuberculosis KasA.mBio. 2018 Dec 18;9(6):e02101-17. doi: 10.1128/mBio.02101-17.
182 Mycobacterium tuberculosis antigens repress Th1 immune response suppression and promotes lung cancer metastasis through PD-1/PDl-1 signaling pathway.Cell Death Dis. 2019 Jan 18;10(2):44. doi: 10.1038/s41419-018-1237-y.
183 ERAP1 and PDE8A Are Downregulated in Cattle Protected against Bovine Tuberculosis.J Mol Microbiol Biotechnol. 2017;27(4):237-245. doi: 10.1159/000479183. Epub 2017 Sep 14.
184 Determinants of substrate specificity in D-3-phosphoglycerate dehydrogenase. Conversion of the M. tuberculosis enzyme from one that does not use -ketoglutarate as a substrate to one that does.Arch Biochem Biophys. 2019 Aug 15;671:218-224. doi: 10.1016/j.abb.2019.07.016. Epub 2019 Jul 22.
185 RNase 7 but not psoriasin nor sPLA2-IIA associates with Mycobacterium tuberculosis during airway epithelial cell infection.Pathog Dis. 2018 Mar 1;76(2). doi: 10.1093/femspd/fty005.
186 Assessing the role of deoD gene in Mycobacterium tuberculosis in vitro growth and macrophage infection.Microb Pathog. 2018 Jun;119:60-64. doi: 10.1016/j.micpath.2018.03.056. Epub 2018 Mar 30.
187 Mitochondrial cyclophilin D regulates T cell metabolic responses and disease tolerance to tuberculosis.Sci Immunol. 2018 May 11;3(23):eaar4135. doi: 10.1126/sciimmunol.aar4135.
188 Mycobacterium tuberculosis exploits the PPM1A signaling pathway to block host macrophage apoptosis.Sci Rep. 2017 Feb 8;7:42101. doi: 10.1038/srep42101.
189 PP2Ac Modulates AMPK-Mediated Induction of Autophagy in Mycobacterium bovis-Infected Macrophages.Int J Mol Sci. 2019 Nov 29;20(23):6030. doi: 10.3390/ijms20236030.
190 A lipidated bi-epitope vaccine comprising of MHC-I and MHC-II binder peptides elicits protective CD4 T cell and CD8 T cell immunity against Mycobacterium tuberculosis.J Transl Med. 2018 Oct 11;16(1):279. doi: 10.1186/s12967-018-1653-x.
191 Protein kinase C-delta (PKC), a marker of inflammation and tuberculosis disease progression in humans, is important for optimal macrophage killing effector functions and survival in mice.Mucosal Immunol. 2018 Mar;11(2):496-511. doi: 10.1038/mi.2017.68. Epub 2017 Aug 9.
192 Association of LMP/TAP gene polymorphisms with tuberculosis susceptibility in Li population in China.PLoS One. 2012;7(3):e33051. doi: 10.1371/journal.pone.0033051. Epub 2012 Mar 12.
193 Evaluation of facility and community-based active household tuberculosis contact investigation in Ethiopia: a cross-sectional study.BMC Health Serv Res. 2019 Apr 22;19(1):234. doi: 10.1186/s12913-019-4074-5.
194 Infection-Induced Vascular Permeability Aids Mycobacterial Growth.J Infect Dis. 2017 Mar 1;215(5):813-817. doi: 10.1093/infdis/jiw355.
195 Discovery of susceptibility loci associated with tuberculosis in Han Chinese.Hum Mol Genet. 2017 Dec 1;26(23):4752-4763. doi: 10.1093/hmg/ddx365.
196 Catalysing the development and introduction of paediatric drug formulations for children living with HIV: a new global collaborative framework for action.Lancet HIV. 2018 May;5(5):e259-e264. doi: 10.1016/S2352-3018(18)30005-5. Epub 2018 May 1.
197 RIPK2 polymorphisms and susceptibility to tuberculosis in a Western Chinese Han population.Infect Genet Evol. 2019 Nov;75:103950. doi: 10.1016/j.meegid.2019.103950. Epub 2019 Jul 3.
198 TB/HIV pleurisy reduces Th17 lymphocyte proportion independent of the cytokine microenvironment.Tuberculosis (Edinb). 2016 Jul;99:92-99. doi: 10.1016/j.tube.2016.05.001. Epub 2016 May 6.
199 Identification of Species of Nontuberculous Mycobacteria Clinical Isolates from 8 Provinces of China.Biomed Res Int. 2016;2016:2153910. doi: 10.1155/2016/2153910. Epub 2016 Nov 2.
200 Fishing for Answers in Human Mycobacterial Infections.Immunity. 2017 Sep 19;47(3):395-397. doi: 10.1016/j.immuni.2017.09.005.
201 Complement Dependent and Independent Interaction Between Bovine Conglutinin and Mycobacterium bovis BCG: Implications in Bovine Tuberculosis.Front Immunol. 2019 Feb 5;9:3159. doi: 10.3389/fimmu.2018.03159. eCollection 2018.
202 Routinely detected indicators in plasma have a predictive effect on the identification of HIV-infected patients with non-tuberculous mycobacterial and tuberculous infections.Infect Dis Poverty. 2017 Nov 2;6(1):132. doi: 10.1186/s40249-017-0347-6.
203 Role of pharmacogenetics in rifampicin pharmacokinetics and the potential effect on TB-rifampicin sensitivity among Ugandan patients.Trans R Soc Trop Med Hyg. 2020 Feb 7;114(2):107-114. doi: 10.1093/trstmh/trz108.
204 Crosstalk Between Sphingomyelinases and Reactive Oxygen Species in Mycobacterial Infection.Antioxid Redox Signal. 2018 Apr 1;28(10):935-948. doi: 10.1089/ars.2017.7050. Epub 2017 Apr 6.
205 Early secreted antigen ESAT-6 of Mycobacterium Tuberculosis promotes apoptosis of macrophages via targeting the microRNA155-SOCS1 interaction.Cell Physiol Biochem. 2015;35(4):1276-88. doi: 10.1159/000373950. Epub 2015 Feb 11.
206 Interaction of the CD43 Sialomucin with the Mycobacterium tuberculosis Cpn60.2 Chaperonin Leads to Tumor Necrosis Factor Alpha Production.Infect Immun. 2017 Feb 23;85(3):e00915-16. doi: 10.1128/IAI.00915-16. Print 2017 Mar.
207 Association of polymorphisms of the transporter associated with antigen processing (TAP2) gene with pulmonary tuberculosis in an elderly Japanese population.APMIS. 2016 Aug;124(8):675-80. doi: 10.1111/apm.12562. Epub 2016 Jun 21.
208 Analysis of transcription factors, microRNAs and cytokines involved in T lymphocyte differentiation in patients with tuberculosis after directly observed treatment short-course.Tuberculosis (Edinb). 2017 Jul;105:1-8. doi: 10.1016/j.tube.2017.03.007. Epub 2017 Mar 28.
209 Activation of TLR7 Inhibition of Mycobacterium Tuberculosis Survival by Autophagy in RAW 264.7 Macrophages.J Cell Biochem. 2017 Dec;118(12):4222-4229. doi: 10.1002/jcb.26072. Epub 2017 May 23.
210 Association of TLR8 and TLR9 polymorphisms with tuberculosis in a Chinese Han population: a case-control study.BMC Infect Dis. 2018 Nov 13;18(1):561. doi: 10.1186/s12879-018-3485-y.
211 4-1BB expression on MAIT cells is associated with enhanced IFN- production and depends on IL-2.Cell Immunol. 2018 Jun;328:58-69. doi: 10.1016/j.cellimm.2018.03.013. Epub 2018 Mar 31.
212 A Nanostructured Lipid System to Improve the Oral Bioavailability of Ruthenium(II) Complexes for the Treatment of Infections Caused by Mycobacterium tuberculosis.Front Microbiol. 2018 Dec 6;9:2930. doi: 10.3389/fmicb.2018.02930. eCollection 2018.
213 Immunoscreening of the M. tuberculosis F15/LAM4/KZN secretome library against TB patients' sera identifies unique active- and latent-TB specific biomarkers.Tuberculosis (Edinb). 2019 Mar;115:161-170. doi: 10.1016/j.tube.2019.03.005. Epub 2019 Mar 15.
214 Enterokinase monolithic bioreactor as an efficient tool for biopharmaceuticals preparation: on-line cleavage of fusion proteins and analytical characterization of released products.J Pharm Biomed Anal. 2018 Aug 5;157:10-19. doi: 10.1016/j.jpba.2018.05.005. Epub 2018 May 4.
215 The short-chain dehydrogenases/reductases (SDR) gene: A new specific target for rapid detection of Mycobacterium tuberculosis complex by modified comparative genomic analysis.Infect Genet Evol. 2019 Jun;70:158-164. doi: 10.1016/j.meegid.2019.01.012. Epub 2019 Jan 12.
216 Genetic Polymorphisms of SLCO1B1, CYP2E1 and UGT1A1 and Susceptibility to Anti-Tuberculosis Drug-Induced Hepatotoxicity: A Chinese Population-Based Prospective Case-Control Study.Clin Drug Investig. 2017 Dec;37(12):1125-1136. doi: 10.1007/s40261-017-0572-6.
217 Structural investigations on orotate phosphoribosyltransferase from Mycobacterium tuberculosis, a key enzyme of the de novo pyrimidine biosynthesis.Sci Rep. 2017 Apr 26;7(1):1180. doi: 10.1038/s41598-017-01057-z.
218 Inhibition of Pseudomonas aeruginosa and Mycobacterium tuberculosis disulfide bond forming enzymes.Mol Microbiol. 2019 Apr;111(4):918-937. doi: 10.1111/mmi.14185. Epub 2019 Mar 18.
219 Role of polymorphic bile salt export pump (BSEP, ABCB11) transporters in anti-tuberculosis drug-induced liver injury in a Chinese cohort.Sci Rep. 2016 Jun 13;6:27750. doi: 10.1038/srep27750.
220 Improved early diagnosis of difficult cases of tuberculous pleural effusion by combination of thoracoscopy with immunological tests.Int J Infect Dis. 2019 Apr;81:38-42. doi: 10.1016/j.ijid.2019.01.045. Epub 2019 Jan 30.
221 Paediatric deaths in a tertiary government hospital setting, Malawi.Paediatr Int Child Health. 2019 Nov;39(4):240-248. doi: 10.1080/20469047.2018.1536873. Epub 2018 Nov 19.
222 Mycobacterium tuberculosis AtsG (Rv0296c), GlmU (Rv1018c) and SahH (Rv3248c) Proteins Function as the Human IL-8-Binding Effectors and Contribute to Pathogen Entry into Human Neutrophils.PLoS One. 2016 Feb 1;11(2):e0148030. doi: 10.1371/journal.pone.0148030. eCollection 2016.
223 Nitric oxide prevents a pathogen-permissive granulocytic inflammation during tuberculosis.Nat Microbiol. 2017 May 15;2:17072. doi: 10.1038/nmicrobiol.2017.72.
224 Real time PCR in childhood tuberculosis: a valuable diagnostic tool.Indian J Pediatr. 2015 Feb;82(2):189-91. doi: 10.1007/s12098-014-1506-4. Epub 2014 Jul 17.
225 Lansoprazole-sulfide, pharmacokinetics of this promising anti-tuberculous agent.Biomed Chromatogr. 2017 Dec;31(12). doi: 10.1002/bmc.4035. Epub 2017 Jul 13.
226 Neutrophils from pulmonary tuberculosis patients show augmented levels of chemokines MIP-1, IL-8 and MCP-1 which further increase upon in vitro infection with mycobacterial strains.Hum Immunol. 2014 Aug;75(8):914-22. doi: 10.1016/j.humimm.2014.06.020. Epub 2014 Jun 30.
227 The Application of T.SPOT-TB Assay for Early Diagnosis of Active Tuberculosis in Chronic Kidney Disease Patients Receiving Immunosuppressive Treatment.J Invest Surg. 2020 Oct;33(9):853-858. doi: 10.1080/08941939.2019.1566417. Epub 2019 Mar 27.
228 Percutaneous Pedicle Screw Fixation Alone Versus Debridement and Fusion Surgery for the Treatment of Early Spinal Tuberculosis: A Retrospective Cohort Study.Med Sci Monit. 2019 Feb 27;25:1549-1557. doi: 10.12659/MSM.912538.
229 Establishing Dosing Recommendations for Efavirenz in HIV/TB-Coinfected Children Younger Than 3 Years.J Acquir Immune Defic Syndr. 2019 Aug 1;81(4):473-480. doi: 10.1097/QAI.0000000000002061.
230 Association of genetic polymorphisms of CYP2E1, NAT2, GST and SLCO1B1 with the risk of anti-tuberculosis drug-induced liver injury: a systematic review and meta-analysis.BMJ Open. 2019 Aug 1;9(8):e027940. doi: 10.1136/bmjopen-2018-027940.
231 Genome-wide expression for diagnosis of pulmonary tuberculosis: a multicohort analysis.Lancet Respir Med. 2016 Mar;4(3):213-24. doi: 10.1016/S2213-2600(16)00048-5. Epub 2016 Feb 20.
232 Comparative study of IgA VH 3 gene usage in healthy TST(-) and TST(+) population exposed to tuberculosis: deep sequencing analysis.Immunology. 2015 Feb;144(2):302-11. doi: 10.1111/imm.12372.
233 Identification of 10 Candidate Biomarkers Distinguishing Tuberculous and Malignant Pleural Fluid by Proteomic Methods.Yonsei Med J. 2017 Nov;58(6):1144-1151. doi: 10.3349/ymj.2017.58.6.1144.
234 Liver X receptor gene polymorphisms in tuberculosis: effect on susceptibility.PLoS One. 2014 May 1;9(5):e95954. doi: 10.1371/journal.pone.0095954. eCollection 2014.
235 Growth factor receptor bound protein 2-associated binder 2, a scaffolding adaptor protein, negatively regulates host immunity against tuberculosis.Am J Respir Cell Mol Biol. 2014 Oct;51(4):575-85. doi: 10.1165/rcmb.2013-0329OC.
236 Investigating the Role of Gene-Gene Interactions in TB Susceptibility.PLoS One. 2015 Apr 28;10(4):e0123970. doi: 10.1371/journal.pone.0123970. eCollection 2014.
237 IL-28B down-regulates regulatory T cells but does not improve the protective immunity following tuberculosis subunit vaccine immunization.Int Immunol. 2016 Feb;28(2):77-85. doi: 10.1093/intimm/dxv061. Epub 2015 Oct 31.
238 IL-22 produced by type 3 innate lymphoid cells (ILC3s) reduces the mortality of type 2 diabetes mellitus (T2DM) mice infected with Mycobacterium tuberculosis.PLoS Pathog. 2019 Dec 6;15(12):e1008140. doi: 10.1371/journal.ppat.1008140. eCollection 2019 Dec.
239 Genome-wide association study of ancestry-specific TB risk in the South African Coloured population.Hum Mol Genet. 2014 Feb 1;23(3):796-809. doi: 10.1093/hmg/ddt462. Epub 2013 Sep 20.
240 Mycobacterium-Infected Dendritic Cells Disseminate Granulomatous Inflammation.Sci Rep. 2015 Oct 30;5:15248. doi: 10.1038/srep15248.
241 Polymorphisms in the prostaglandin receptor EP2 gene confers susceptibility to tuberculosis.Infect Genet Evol. 2016 Dec;46:23-27. doi: 10.1016/j.meegid.2016.10.016. Epub 2016 Oct 22.
242 Phenotypic complementation of genetic immunodeficiency by chronic herpesvirus infection.Elife. 2015 Jan 20;4:e04494. doi: 10.7554/eLife.04494.
243 Crystallographic and solution structure of the N-terminal domain of the Rel protein from Mycobacterium tuberculosis.FEBS Lett. 2017 Aug;591(15):2323-2337. doi: 10.1002/1873-3468.12739. Epub 2017 Jul 25.
244 Design of Isoniazid Smart Nanogel by Gamma Radiation-Induced Template Polymerization for Biomedical Application.Pharm Res. 2017 Sep;34(9):1872-1885. doi: 10.1007/s11095-017-2196-1. Epub 2017 Jun 15.
245 Proteomic profiling of serum from patients with tuberculosis.Ann Lab Med. 2014 Sep;34(5):345-53. doi: 10.3343/alm.2014.34.5.345. Epub 2014 Aug 21.
246 Association of polymorphisms in drug transporter genes (SLCO1B1 and SLC10A1) and anti-tuberculosis drug-induced hepatotoxicity in a Chinese cohort.Tuberculosis (Edinb). 2015 Jan;95(1):68-74. doi: 10.1016/j.tube.2014.11.004. Epub 2014 Nov 27.
247 Constitutive STAT3 phosphorylation and IL-6/IL-10 co-expression are associated with impaired T-cell function in tuberculosis patients.Cell Mol Immunol. 2019 Mar;16(3):275-287. doi: 10.1038/cmi.2018.5. Epub 2018 Mar 19.
248 Expanding the ubiquitin code through post-translational modification.EMBO Rep. 2015 Sep;16(9):1071-83. doi: 10.15252/embr.201540891. Epub 2015 Aug 12.
249 Toll-like receptors blocking restores in vitro microbicidal activity in latent tuberculosis-infected subjects.Int J Tuberc Lung Dis. 2019 Feb 1;23(2):212-218. doi: 10.5588/ijtld.18.0392.
250 Targeting DNA Gyrase to Combat Mycobacterium tuberculosis: An Update.Curr Top Med Chem. 2019;19(8):579-593. doi: 10.2174/1568026619666190304130218.
251 Human ULK1 Variation and Susceptibility to Mycobacterium tuberculosis Infection.J Infect Dis. 2016 Oct 15;214(8):1260-7. doi: 10.1093/infdis/jiw347. Epub 2016 Aug 2.
252 MspA-Mycobacterium tuberculosis-transformant with reduced virulence: the "unbirthday paradigm".Microb Pathog. 2014 Nov;76:10-8. doi: 10.1016/j.micpath.2014.08.003. Epub 2014 Sep 3.
253 Association analysis of susceptibility candidate region on chromosome 5q31 for tuberculosis.Genes Immun. 2010 Jul;11(5):416-22. doi: 10.1038/gene.2010.26. Epub 2010 May 20.
254 Recombinant preparation and functional studies of EspI ATP binding domain from Mycobacterium tuberculosis.Protein Expr Purif. 2016 Jul;123:51-9. doi: 10.1016/j.pep.2016.03.009. Epub 2016 Mar 25.
255 Common variants at 11p13 are associated with susceptibility to tuberculosis.Nat Genet. 2012 Feb 5;44(3):257-9. doi: 10.1038/ng.1080.
256 Geographic accessibility to public health facilities providing tuberculosis testing services at point-of-care in the upper east region, Ghana.BMC Public Health. 2019 Jun 10;19(1):718. doi: 10.1186/s12889-019-7052-2.
257 The genetic variants in calcium signaling related genes influence anti-tuberculosis drug induced liver injury: A prospective study.Medicine (Baltimore). 2019 Nov;98(44):e17821. doi: 10.1097/MD.0000000000017821.
258 P2X7 and NRAMP1/SLC11 A1 gene polymorphisms in Mexican mestizo patients with pulmonary tuberculosis.Clin Exp Immunol. 2007 Jun;148(3):469-77. doi: 10.1111/j.1365-2249.2007.03359.x.
259 Characterization of rifampin-resistant Staphylococcus aureus nasal carriage in patients receiving rifampin-containing regimens for tuberculosis.Infect Drug Resist. 2018 Aug 14;11:1175-1182. doi: 10.2147/IDR.S163634. eCollection 2018.
260 Elemental Ingredients in the Macrophage Cocktail: Role of ZIP8 in Host Response to Mycobacterium tuberculosis.Int J Mol Sci. 2017 Nov 9;18(11):2375. doi: 10.3390/ijms18112375.
261 Functional polymorphisms in CYP2C19 & CYP3A5 genes associated with decreased susceptibility for paediatric tuberculosis.Indian J Med Res. 2012 May;135(5):642-9.
262 Detection and identification of mycobacteria by amplification of RNA and DNA in pretreated blood and bone marrow aspirates by a simple lysis method.J Clin Microbiol. 1997 Aug;35(8):2124-8. doi: 10.1128/jcm.35.8.2124-2128.1997.
263 Elevated level of serum LDH2 and LDH3 in sputum three positive TB patients of Sahariya tribe: a preliminary study.Clin Biochem. 2007 Dec;40(18):1414-9. doi: 10.1016/j.clinbiochem.2007.04.024. Epub 2007 Jul 27.
264 Performance of Homologous and Heterologous Prime-Boost Immunization Regimens of Recombinant Adenovirus and Modified Vaccinia Virus Ankara Expressing an Ag85B-TB10.4 Fusion Protein against Mycobacterium tuberculosis.J Microbiol Biotechnol. 2018 Jun 28;28(6):1022-1029. doi: 10.4014/jmb.1712.12064.
265 Vitamin A metabolism by dendritic cells triggers an antimicrobial response against Mycobacterium tuberculosis. mSphere. 2019 Jun 5;4(3). pii: e00327-19.
266 Mycobacterium tuberculosis nucleoside diphosphate kinase shows interaction with putative ATP binding cassette (ABC) transporter, Rv1273c.J Biomol Struct Dyn. 2020 Mar;38(4):1083-1093. doi: 10.1080/07391102.2019.1595150. Epub 2019 Apr 7.
267 Vitamin D-Mediated Hypercalcemia: Mechanisms, Diagnosis, and Treatment.Endocr Rev. 2016 Oct;37(5):521-547. doi: 10.1210/er.2016-1070. Epub 2016 Sep 2.
268 New variant identified in major susceptibility locus to tuberculosis on chromosomal region 8q12-q13 in Moroccan population: a case control study.BMC Infect Dis. 2017 Nov 7;17(1):712. doi: 10.1186/s12879-017-2807-9.
269 Structure Guided Lead Generation toward Nonchiral M. tuberculosis Thymidylate Kinase Inhibitors.J Med Chem. 2018 Apr 12;61(7):2753-2775. doi: 10.1021/acs.jmedchem.7b01570. Epub 2018 Mar 15.
270 An ancestral human genetic variant linked to an ancient disease: A novel association of FMO2 polymorphisms with tuberculosis (TB) in Ethiopian populations provides new insight into the differential ethno-geographic distribution of FMO2*1.PLoS One. 2017 Oct 5;12(10):e0184931. doi: 10.1371/journal.pone.0184931. eCollection 2017.
271 Coenzyme F(420)-Dependent Glucose-6-Phosphate Dehydrogenase-Coupled Polyglutamylation of Coenzyme F(420) in Mycobacteria.J Bacteriol. 2018 Nov 6;200(23):e00375-18. doi: 10.1128/JB.00375-18. Print 2018 Dec 1.
272 Liver toxicity associated with tuberculosis chemotherapy in the REMoxTB study.BMC Med. 2018 Mar 28;16(1):46. doi: 10.1186/s12916-018-1033-7.
273 Relationship of anti-tuberculosis drug-induced liver injury and genetic polymorphisms in CYP2E1 and GST.Braz J Infect Dis. 2019 Nov-Dec;23(6):381-387. doi: 10.1016/j.bjid.2019.09.003. Epub 2019 Nov 4.
274 Dual-targeted hit identification using pharmacophore screening.J Comput Aided Mol Des. 2019 Nov;33(11):955-964. doi: 10.1007/s10822-019-00245-5. Epub 2019 Nov 6.
275 Human Mycobacterium bovis infection in Castile and Len (Spain), 2006-2015.Enferm Infecc Microbiol Clin (Engl Ed). 2019 Jan;37(1):19-24. doi: 10.1016/j.eimc.2017.11.018. Epub 2017 Dec 21.
276 The burden of vaccine-preventable diseases among HIV-infected and HIV-exposed children in sub-Saharan Africa: a systematic review and meta-analysis.Hum Vaccin Immunother. 2019;15(11):2590-2605. doi: 10.1080/21645515.2019.1599676. Epub 2019 May 22.
277 Immune response elicited by two rBCG strains devoid of genes involved in c-di-GMP metabolism affect protection versus challenge with M. tuberculosis strains of different virulence.Vaccine. 2018 Apr 12;36(16):2069-2078. doi: 10.1016/j.vaccine.2018.03.014. Epub 2018 Mar 15.
278 Simultaneous amplification and testing method for Mycobacterium tuberculosis rRNA to differentiate sputum-negative tuberculosis from sarcoidosis.Am J Physiol Lung Cell Mol Physiol. 2019 Mar 1;316(3):L519-L524. doi: 10.1152/ajplung.00172.2018. Epub 2019 Jan 17.
279 Association of UGT2B7 polymorphisms with risk of induced liver injury by anti-tuberculosis drugs in Chinese Han.Int J Immunopathol Pharmacol. 2017 Dec;30(4):434-438. doi: 10.1177/0394632017733638. Epub 2017 Sep 22.
280 Analysis of uracil phosphoribosyltransferase expression in Mycobacterium tuberculosis and evaluation of upp knockout strain in infected mice.FEMS Microbiol Lett. 2017 Feb 1;364(4). doi: 10.1093/femsle/fnx023.
281 CYP7A1, BAAT and UGT1A1 polymorphisms and susceptibility to anti-tuberculosis drug-induced hepatotoxicity.Int J Tuberc Lung Dis. 2016 Jun;20(6):812-8. doi: 10.5588/ijtld.15.0450.
282 Vitamin D deficiency associates with susceptibility to tuberculosis in Pakistan, but polymorphisms in VDR, DBP and CYP2R1 do not.BMC Pulm Med. 2016 May 10;16(1):73. doi: 10.1186/s12890-016-0240-2.
283 Genome-wide association study identifies two risk loci for tuberculosis in Han Chinese.Nat Commun. 2018 Oct 4;9(1):4072. doi: 10.1038/s41467-018-06539-w.
284 Bulgarian specificity and controversial phylogeography of Mycobacterium tuberculosis spoligotype ST 125__BGR.FEMS Immunol Med Microbiol. 2010 Jun 1;59(1):90-9. doi: 10.1111/j.1574-695X.2010.00667.x. Epub 2010 Mar 4.
285 Relationship between single nucleotide polymorphism of interleukin-18 and susceptibility to pulmonary tuberculosis in the Chinese Han population.Microbiol Immunol. 2011 Jun;55(6):388-93. doi: 10.1111/j.1348-0421.2011.00332.x.
286 Contribution of AGC to ACC and other mutations at codon 315 of the katG gene in isoniazid-resistant Mycobacterium tuberculosis isolates from the Middle East.Int J Antimicrob Agents. 2004 May;23(5):473-9. doi: 10.1016/j.ijantimicag.2003.10.004.
287 Influence of variations in CCL3L1 and CCR5 on tuberculosis in a northwestern Colombian population.J Infect Dis. 2011 Jun 1;203(11):1590-4. doi: 10.1093/infdis/jir145.
288 Evaluation of the hyplex TBC PCR test for detection of Mycobacterium tuberculosis complex in clinical samples.BMC Microbiol. 2010 Mar 31;10:95. doi: 10.1186/1471-2180-10-95.
289 Genetic susceptibility to tuberculosis associated with cathepsin Z haplotype in a Ugandan household contact study.Hum Immunol. 2011 May;72(5):426-30. doi: 10.1016/j.humimm.2011.02.016. Epub 2011 Feb 25.
290 Gene expression in HIV-1/Mycobacterium tuberculosis co-infected macrophages is dominated by M. tuberculosis.Tuberculosis (Edinb). 2009 Jul;89(4):285-93. doi: 10.1016/j.tube.2009.05.003. Epub 2009 Jun 10.
291 Levofloxacin versus placebo for the prevention of tuberculosis disease in child contacts of multidrug-resistant tuberculosis: study protocol for a phase III cluster randomised controlled trial (TB-CHAMP).Trials. 2018 Dec 20;19(1):693. doi: 10.1186/s13063-018-3070-0.
292 Emergent Role of Coronin-1a in Neuronal Signaling.Vitam Horm. 2017;104:113-131. doi: 10.1016/bs.vh.2016.10.002. Epub 2016 Nov 29.
293 Early identification of Mycobacterium tuberculosis complex in BACTEC cultures by ligase chain reaction.J Med Microbiol. 2002 Aug;51(8):710-712. doi: 10.1099/0022-1317-51-8-710.
294 Microarray analysis of gene expression associated with extrapulmonary dissemination of tuberculosis.Respirology. 2006 Sep;11(5):557-65. doi: 10.1111/j.1440-1843.2006.00896.x.
295 ATP-dependent MurE ligase in Mycobacterium tuberculosis: biochemical and structural characterisation.Tuberculosis (Edinb). 2010 Jan;90(1):16-24. doi: 10.1016/j.tube.2009.10.007. Epub 2009 Nov 27.
296 Immunostimulatory activity of recombinant Mycobacterium bovis BCG that secretes major membrane protein II of Mycobacterium leprae.Infect Immun. 2006 Nov;74(11):6264-71. doi: 10.1128/IAI.00878-06.
297 Turning Off the Tap: Using the FAST Approach to Stop the Spread of Drug-Resistant Tuberculosis in the Russian Federation.J Infect Dis. 2018 Jul 13;218(4):654-658. doi: 10.1093/infdis/jiy190.
298 Application of infrequent-restriction-site amplification for genotyping of Mycobacterium tuberculosis and non-tuberculous mycobacterium.J Korean Med Sci. 2002 Oct;17(5):593-8. doi: 10.3346/jkms.2002.17.5.593.
299 Association between IFNA genotype and the risk of sarcoidosis.Hum Genet. 2004 Apr;114(5):503-9. doi: 10.1007/s00439-004-1099-5. Epub 2004 Mar 5.
300 Biochemical and transcription analysis of acetohydroxyacid synthase isoforms in Mycobacterium tuberculosis identifies these enzymes as potential targets for drug development.Microbiology (Reading). 2011 Jan;157(Pt 1):29-37. doi: 10.1099/mic.0.041343-0. Epub 2010 Sep 30.
301 Specificities and functions of the recA and pps1 intein genes of Mycobacterium tuberculosis and application for diagnosis of tuberculosis.J Clin Microbiol. 2002 Mar;40(3):943-50. doi: 10.1128/JCM.40.3.943-950.2002.
302 Role played by human mannose-binding lectin polymorphisms in pulmonary tuberculosis.J Infect Dis. 2009 Mar 1;199(5):666-72. doi: 10.1086/596658.
303 Identification of virulence determinants of Mycobacterium avium that impact on the ability to resist host killing mechanisms.J Med Microbiol. 2010 Jan;59(Pt 1):8-16. doi: 10.1099/jmm.0.012864-0.
304 Studies of polymorphic DNA fingerprinting and lipid pattern of Mycobacterium tuberculosis patient isolates in Japan.Microbiol Immunol. 1997;41(2):107-19. doi: 10.1111/j.1348-0421.1997.tb01176.x.
305 Genome-wide association studies of tuberculosis in Asians identify distinct at-risk locus for young tuberculosis.J Hum Genet. 2012 Jun;57(6):363-7. doi: 10.1038/jhg.2012.35. Epub 2012 May 3.
306 Knops blood group polymorphism and susceptibility to Mycobacterium tuberculosis infection.Transfusion. 2011 Nov;51(11):2462-9. doi: 10.1111/j.1537-2995.2011.03161.x. Epub 2011 May 13.
307 Characterization of Mycobacterium paratuberculosis p36 antigen and its seroreactivities in Crohn's disease.Curr Microbiol. 1999 Aug;39(2):115-9. doi: 10.1007/s002849900430.
308 Analysis of IL1B, TAP1, TAP2 and IKBL polymorphisms on susceptibility to tuberculosis.Tissue Antigens. 2006 Apr;67(4):290-6. doi: 10.1111/j.1399-0039.2006.00566.x.
309 The CATERPILLER protein monarch-1 is an antagonist of toll-like receptor-, tumor necrosis factor alpha-, and Mycobacterium tuberculosis-induced pro-inflammatory signals.J Biol Chem. 2005 Dec 2;280(48):39914-24. doi: 10.1074/jbc.M502820200. Epub 2005 Oct 3.
310 Haptoglobin polymorphism and mortality in patients with tuberculosis.Int J Tuberc Lung Dis. 2000 Aug;4(8):771-5.
311 [Study of the polymorphic markers--the PARK2 and PACRG genes due to the incidence of pulmonary tuberculosis in two districts of the Republic of Tyva].Probl Tuberk Bolezn Legk. 2007;(7):27-9.
312 Familial hemophagocytic lymphohistiocytosis in an adult patient homozygous for A91V in the perforin gene, with tuberculosis infection.Haematologica. 2006 Sep;91(9):1257-60.
313 PCR assay based on DNA coding for 16S rRNA for detection and identification of mycobacteria in clinical samples.J Clin Microbiol. 1995 Dec;33(12):3225-33. doi: 10.1128/jcm.33.12.3225-3233.1995.
314 Rhomboid homologs in mycobacteria: insights from phylogeny and genomic analysis.BMC Microbiol. 2010 Oct 29;10:272. doi: 10.1186/1471-2180-10-272.
315 The detection of Mycobacterium tuberculosis in uncultured clinical specimens using the polymerase chain reaction and a non-radioactive DNA probe.Mol Cell Probes. 1992 Jun;6(3):181-91. doi: 10.1016/0890-8508(92)90015-p.
316 Proliferative response of peripheral blood mononuclear cells and levels of antibody to recombinant protein from Propionibacterium acnes DNA expression library in Japanese patients with sarcoidosis.Sarcoidosis Vasc Diffuse Lung Dis. 2000 Oct;17(3):256-65.
317 Performance assessment of a nested-PCR assay (the RAPID BAP-MTB) and the BD ProbeTec ET system for detection of Mycobacterium tuberculosis in clinical specimens.J Clin Microbiol. 2004 Oct;42(10):4599-603. doi: 10.1128/JCM.42.10.4599-4603.2004.
318 Expression of signaling lymphocytic activation molecule-associated protein interrupts IFN-gamma production in human tuberculosis.J Immunol. 2004 Jan 15;172(2):1177-85. doi: 10.4049/jimmunol.172.2.1177.
319 Comparison of the Roche AMPLICOR MYCOBACTERIUM assay and Digene SHARP Signal System with in-house PCR and culture for detection of Mycobacterium tuberculosis in respiratory specimens.J Clin Microbiol. 1996 Dec;34(12):3092-6. doi: 10.1128/jcm.34.12.3092-3096.1996.
320 HLA antigen profile in pulmonary tuberculosis patients & their spouses.Indian J Med Res. 1998 Apr;107:155-8.
321 IRF and tuberculosis.J Interferon Cytokine Res. 2002 Jan;22(1):15-25. doi: 10.1089/107999002753452629.
322 Polymorphisms in autophagy genes and susceptibility to tuberculosis.PLoS One. 2012;7(8):e41618. doi: 10.1371/journal.pone.0041618. Epub 2012 Aug 6.
323 Association of variable number of tandem repeats in the coding region of the FAM46A gene, FAM46A rs11040 SNP and BAG6 rs3117582 SNP with susceptibility to tuberculosis.PLoS One. 2014 Mar 13;9(3):e91385. doi: 10.1371/journal.pone.0091385. eCollection 2014.
324 Activation of P-TEFb at sites of dual HIV/TB infection, and inhibition of MTB-induced HIV transcriptional activation by the inhibitor of CDK9, Indirubin-3'-monoxime.AIDS Res Hum Retroviruses. 2012 Feb;28(2):182-7. doi: 10.1089/aid.2010.0211. Epub 2011 May 6.
325 Serum anti-CCNY autoantibody is an independent prognosis indicator for postoperative patients with early-stage nonsmall-cell lung carcinoma.Dis Markers. 2013;35(5):317-25. doi: 10.1155/2013/935943. Epub 2013 Sep 18.
326 The study of novel DNA vaccines against tuberculosis: induction of pathogen-specific CTL in the mouse and monkey models of tuberculosis.Hum Vaccin Immunother. 2013 Mar;9(3):515-25. doi: 10.4161/hv.23229. Epub 2012 Dec 18.
327 A functional promoter polymorphism of IFITM3 is associated with susceptibility to pediatric tuberculosis in Han Chinese population.PLoS One. 2013 Jul 9;8(7):e67816. doi: 10.1371/journal.pone.0067816. Print 2013.
328 IL-10R1 S138G loss-of-function polymorphism is associated with extrapulmonary tuberculosis risk development in Tunisia.Mol Biol Rep. 2012 Jan;39(1):51-6. doi: 10.1007/s11033-011-0709-2. Epub 2011 May 8.
329 Identification of genetic associations of SP110/MYBBP1A/RELA with pulmonary tuberculosis in the Chinese Han population.Hum Genet. 2013 Mar;132(3):265-73. doi: 10.1007/s00439-012-1244-5. Epub 2012 Nov 6.
330 Characterization of phosphofructokinase activity in Mycobacterium tuberculosis reveals that a functional glycolytic carbon flow is necessary to limit the accumulation of toxic metabolic intermediates under hypoxia.PLoS One. 2013;8(2):e56037. doi: 10.1371/journal.pone.0056037. Epub 2013 Feb 7.
331 Rapid identification of mycobacteria and drug-resistant Mycobacterium tuberculosis by use of a single multiplex PCR and DNA sequencing.J Clin Microbiol. 2012 Feb;50(2):326-36. doi: 10.1128/JCM.05570-11. Epub 2011 Dec 7.
332 Non-chemotactic influence of CXCL7 on human phagocytes. Modulation of antimicrobial activity against L. pneumophila.Immunobiology. 2012 Apr;217(4):394-401. doi: 10.1016/j.imbio.2011.10.015. Epub 2011 Nov 3.
333 Diagnostic luciferase reporter phage assay for active and non-replicating persistors to detect tubercle bacilli from sputum samples.Clin Microbiol Infect. 2012 May;18(5):492-6. doi: 10.1111/j.1469-0691.2011.03592.x. Epub 2011 Aug 16.
334 The conservation and application of three hypothetical protein coding gene for direct detection of Mycobacterium tuberculosis in sputum specimens.PLoS One. 2013 Sep 13;8(9):e73955. doi: 10.1371/journal.pone.0073955. eCollection 2013.
335 Identification of biomarkers for Mycobacterium tuberculosis infection and disease in BCG-vaccinated young children in Southern India.Genes Immun. 2013 Sep;14(6):356-64. doi: 10.1038/gene.2013.26. Epub 2013 May 16.
336 Role of protease inhibitor 9 in survival and replication of Mycobacterium tuberculosis in mononuclear phagocytes from HIV-1-infected patients.AIDS. 2014 Mar 13;28(5):679-87. doi: 10.1097/QAD.0000000000000192.
337 Differential expression of alpha II spectrin in monocytes of tuberculosis patients.Int Immunopharmacol. 2013 Nov;17(3):759-62. doi: 10.1016/j.intimp.2013.09.005. Epub 2013 Sep 18.
338 Xpert MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.Cochrane Database Syst Rev. 2013 Jan 31;(1):CD009593. doi: 10.1002/14651858.CD009593.pub2.
339 Human-Specific Mutations and Positively Selected Sites in MARCO Confer Functional Changes.Mol Biol Evol. 2018 Feb 1;35(2):440-450. doi: 10.1093/molbev/msx298.
340 Impact of nucleic acid amplification test on pulmonary tuberculosis notifications and treatments in Taiwan: a 7-year single-center cohort study.BMC Infect Dis. 2019 Aug 16;19(1):726. doi: 10.1186/s12879-019-4358-8.
341 Positive epistasis of major low-cost drug resistance mutations rpoB531-TTG and katG315-ACC depends on the phylogenetic background of Mycobacterium tuberculosis strains.Int J Antimicrob Agents. 2017 Jun;49(6):757-762. doi: 10.1016/j.ijantimicag.2017.02.009. Epub 2017 Apr 26.
342 Functional annotation of putative fadE9 of Mycobacterium tuberculosis as isobutyryl-CoA dehydrogenase involved in valine catabolism.Int J Biol Macromol. 2019 Feb 1;122:45-57. doi: 10.1016/j.ijbiomac.2018.10.040. Epub 2018 Oct 11.
343 Pituitary tuberculoma: a rare cause of sellar mass.Ir J Med Sci. 2018 May;187(2):461-464. doi: 10.1007/s11845-017-1654-4. Epub 2017 Jul 21.
344 Polymorphisms in interferon pathway genes and risk of Mycobacterium tuberculosis infection in contacts of tuberculosis cases in Brazil.Int J Infect Dis. 2020 Mar;92:21-28. doi: 10.1016/j.ijid.2019.12.013. Epub 2019 Dec 13.
345 Tuberculosis in Pap samples with emphasis on LBC: Caught only when thought.Diagn Cytopathol. 2018 May;46(5):425-428. doi: 10.1002/dc.23865. Epub 2017 Nov 28.
346 Low Vitamin-D Levels Combined with PKP3-SIGIRR-TMEM16J Host Variants Is Associated with Tuberculosis and Death in HIV-Infected and -Exposed Infants.PLoS One. 2016 Feb 12;11(2):e0148649. doi: 10.1371/journal.pone.0148649. eCollection 2016.
347 Altered circulating levels of B cell growth factors and their modulation upon anti-tuberculosis treatment in pulmonary tuberculosis and tuberculous lymphadenitis.PLoS One. 2018 Nov 14;13(11):e0207404. doi: 10.1371/journal.pone.0207404. eCollection 2018.
348 Guanine nucleotide exchange factor -H1 promotes inflammatory cytokine production and intracellular mycobacterial elimination in macrophages.Cell Cycle. 2017 Sep 17;16(18):1695-1704. doi: 10.1080/15384101.2017.1347739. Epub 2017 Aug 7.
349 Crystal structure of the apurinic/apyrimidinic endonuclease IV from Mycobacterium tuberculosis.Biochem Biophys Res Commun. 2018 Mar 25;498(1):111-118. doi: 10.1016/j.bbrc.2018.02.181. Epub 2018 Feb 27.
350 Noninvasive Detection of Tuberculosis by Oral Swab Analysis.J Clin Microbiol. 2019 Feb 27;57(3):e01847-18. doi: 10.1128/JCM.01847-18. Print 2019 Mar.
351 Algorithm-guided empirical tuberculosis treatment for people with advanced HIV (TB Fast Track): an open-label, cluster-randomised trial.Lancet HIV. 2020 Jan;7(1):e27-e37. doi: 10.1016/S2352-3018(19)30266-8. Epub 2019 Nov 11.
352 Crystal structure and biochemical study on argininosuccinate lyase from Mycobacterium tuberculosis.Biochem Biophys Res Commun. 2019 Feb 26;510(1):116-121. doi: 10.1016/j.bbrc.2019.01.061. Epub 2019 Jan 18.
353 Identification and validation of l-asparaginase as a potential metabolic target against Mycobacterium tuberculosis.J Cell Biochem. 2019 Jan;120(1):143-154. doi: 10.1002/jcb.27169. Epub 2018 Sep 19.
354 Mir223 restrains autophagy and promotes CNS inflammation by targeting ATG16L1.Autophagy. 2019 Mar;15(3):478-492. doi: 10.1080/15548627.2018.1522467. Epub 2018 Sep 22.
355 Mycobacterium tuberculosis-induced miR-155 subverts autophagy by targeting ATG3 in human dendritic cells.PLoS Pathog. 2018 Jan 4;14(1):e1006790. doi: 10.1371/journal.ppat.1006790. eCollection 2018 Jan.
356 BATF Potentially Mediates Negative Regulation of PD-1/PD-Ls Pathway on T Cell Functions in Mycobacterium tuberculosis Infection.Front Immunol. 2019 Oct 15;10:2430. doi: 10.3389/fimmu.2019.02430. eCollection 2019.
357 Blood Transcriptomic Stratification of Short-term Risk in Contacts of Tuberculosis.Clin Infect Dis. 2020 Feb 14;70(5):731-737. doi: 10.1093/cid/ciz252.
358 Tuberculin Skin Testing Boosts Interferon Gamma Responses to DIVA Reagents in Mycobacterium bovis-Infected Cattle.Clin Vaccine Immunol. 2017 May 5;24(5):e00551-16. doi: 10.1128/CVI.00551-16. Print 2017 May.
359 Pharmaceutical salts of ethionamide with GRAS counter ion donors to enhance the solubility.Eur J Pharm Sci. 2017 Jan 1;96:578-589. doi: 10.1016/j.ejps.2016.10.035. Epub 2016 Nov 1.
360 CD157 Confers Host Resistance to Mycobacterium tuberculosis via TLR2-CD157-PKCzeta-Induced Reactive Oxygen Species Production.mBio. 2019 Aug 27;10(4):e01949-19. doi: 10.1128/mBio.01949-19.
361 Analysis of the association between BTNL2 polymorphism and tuberculosis in Chinese Han population.Infect Genet Evol. 2010 May;10(4):517-21. doi: 10.1016/j.meegid.2010.02.006. Epub 2010 Feb 20.
362 C5aR contributes to the weak Th1 profile induced by an outbreak strain of Mycobacterium tuberculosis.Tuberculosis (Edinb). 2017 Mar;103:16-23. doi: 10.1016/j.tube.2016.12.005. Epub 2016 Dec 21.
363 Impact of type of calcineurin inhibitor on post-transplant tuberculosis: Single-center study from India.Transpl Infect Dis. 2017 Feb;19(1). doi: 10.1111/tid.12626. Epub 2016 Dec 16.
364 Polymorphisms in CARD8 and NLRP3 are associated with extrapulmonary TB and poor clinical outcome in active TB in Ethiopia.Sci Rep. 2019 Feb 28;9(1):3126. doi: 10.1038/s41598-019-40121-8.
365 Dectin-1-Syk-CARD9 Signaling Pathway in TB Immunity.Front Immunol. 2018 Feb 13;9:225. doi: 10.3389/fimmu.2018.00225. eCollection 2018.
366 Cellular immune response in MDR-TB patients to different protein expression of MDR and susceptible Mycobacterium tuberculosis: Rv0147, a novel MDR-TB biomarker.Immunol Res. 2018 Feb;66(1):59-66. doi: 10.1007/s12026-017-8971-6.
367 Secretome profile analysis of multidrug-resistant, monodrug-resistant and drug-susceptible Mycobacterium tuberculosis.Arch Microbiol. 2018 Mar;200(2):299-309. doi: 10.1007/s00203-017-1448-0. Epub 2017 Nov 8.
368 Genetic polymorphisms of CCL1 rs2072069 G/A and TLR2 rs3804099 T/C in pulmonary or meningeal tuberculosis patients.Int J Clin Exp Pathol. 2015 Oct 1;8(10):12608-20. eCollection 2015.
369 Household contact investigation for the detection of tuberculosis in Vietnam: economic evaluation of a cluster-randomised trial.Lancet Glob Health. 2019 Mar;7(3):e376-e384. doi: 10.1016/S2214-109X(18)30520-5.
370 The N-terminal peptide moiety of the Mycobacterium tuberculosis 19 kDa lipoprotein harbors RP105-agonistic properties.J Leukoc Biol. 2018 Feb;103(2):311-319. doi: 10.1002/JLB.2MA0517-190RR. Epub 2018 Jan 9.
371 Interactions of domain antibody (dAb11) with Mycobacterium tuberculosis Ac(2)SGL in complex with CD1b.Tuberculosis (Edinb). 2019 Jan;114:9-16. doi: 10.1016/j.tube.2018.11.002. Epub 2018 Nov 4.
372 Long noncoding RNA derived from CD244 signaling epigenetically controls CD8+ T-cell immune responses in tuberculosis infection.Proc Natl Acad Sci U S A. 2015 Jul 21;112(29):E3883-92. doi: 10.1073/pnas.1501662112. Epub 2015 Jul 6.
373 Rapid and simple approach for identification of Mycobacterium tuberculosis and M. bovis by detection of regulatory gene whiB7.Acta Microbiol Immunol Hung. 2011 Mar;58(1):65-74. doi: 10.1556/AMicr.58.2011.1.7.
374 Pathogen lineage-based genome-wide association study identified CD53 as susceptible locus in tuberculosis.J Hum Genet. 2017 Dec;62(12):1015-1022. doi: 10.1038/jhg.2017.82. Epub 2017 Sep 7.
375 Cdx-2 polymorphism in the vitamin D receptor gene (VDR) marks VDR expression in monocyte/macrophages through VDR promoter methylation.Immunogenetics. 2018 Aug;70(8):523-532. doi: 10.1007/s00251-018-1063-5. Epub 2018 May 28.
376 Validating a 14-Drug Microtiter Plate Containing Bedaquiline and Delamanid for Large-Scale Research Susceptibility Testing of Mycobacterium tuberculosis.Antimicrob Agents Chemother. 2018 Aug 27;62(9):e00344-18. doi: 10.1128/AAC.00344-18. Print 2018 Sep.
377 A SNP upstream of the cyclic GMP-AMP synthase (cGAS) gene protects from relapse and extra-pulmonary TB and relates to BCG vaccination status in an Indian cohort.Genes Immun. 2020 Jan;21(1):13-26. doi: 10.1038/s41435-019-0080-1. Epub 2019 May 23.
378 Secondary metabolites from Tetracera potatoria stem bark with anti-mycobacterial activity.J Ethnopharmacol. 2017 Jan 4;195:238-245. doi: 10.1016/j.jep.2016.11.027. Epub 2016 Nov 15.
379 A snapshot of the predominant single nucleotide polymorphism cluster groups of Mycobacterium tuberculosis clinical isolates in Delhi, India.Tuberculosis (Edinb). 2016 Sep;100:72-81. doi: 10.1016/j.tube.2016.07.007. Epub 2016 Jul 25.
380 Mycobacterium tuberculosis Controls Phagosomal Acidification by Targeting CISH-Mediated Signaling.Cell Rep. 2017 Sep 26;20(13):3188-3198. doi: 10.1016/j.celrep.2017.08.101.
381 C-type lectin receptor DCIR modulates immunity to tuberculosis by sustaining type I interferon signaling in dendritic cells.Proc Natl Acad Sci U S A. 2017 Jan 24;114(4):E540-E549. doi: 10.1073/pnas.1613254114. Epub 2017 Jan 9.
382 Aryl Trehalose Derivatives as Vaccine Adjuvants for Mycobacterium tuberculosis.J Med Chem. 2020 Jan 9;63(1):309-320. doi: 10.1021/acs.jmedchem.9b01598. Epub 2019 Dec 20.
383 Theranostic Application of a Novel G-Quadruplex-Forming DNA Aptamer Targeting Malate Synthase of Mycobacterium tuberculosis.Mol Ther Nucleic Acids. 2019 Dec 6;18:661-672. doi: 10.1016/j.omtn.2019.09.026. Epub 2019 Oct 4.
384 Structural and mechanistic comparison of the Cyclopropane Mycolic Acid Synthases (CMAS) protein family of Mycobacterium tuberculosis.Biochem Biophys Res Commun. 2018 Mar 29;498(2):288-295. doi: 10.1016/j.bbrc.2017.08.119. Epub 2017 Aug 30.
385 Dual-protected amino acid derivatives as new antitubercular agents.Chem Biol Drug Des. 2018 Aug;92(2):1576-1580. doi: 10.1111/cbdd.13315. Epub 2018 May 31.
386 Drug targeted virtual screening and molecular dynamics of LipU protein of Mycobacterium tuberculosis and Mycobacterium leprae.J Biomol Struct Dyn. 2019 Mar;37(5):1254-1269. doi: 10.1080/07391102.2018.1454852. Epub 2018 Mar 30.
387 Polymorphisms in MC3R promoter and CTSZ 3'UTR are associated with tuberculosis susceptibility.Eur J Hum Genet. 2011 Jun;19(6):676-81. doi: 10.1038/ejhg.2011.1. Epub 2011 Feb 2.
388 CYRI/FAM49B negatively regulates RAC1-driven cytoskeletal remodelling and protects against bacterial infection.Nat Microbiol. 2019 Sep;4(9):1516-1531. doi: 10.1038/s41564-019-0484-8. Epub 2019 Jul 8.
389 Identification and characterization of aspartyl-tRNA synthetase inhibitors against Mycobacterium tuberculosis by an integrated whole-cell target-based approach.Sci Rep. 2018 Aug 23;8(1):12664. doi: 10.1038/s41598-018-31157-3.
390 Sputum Proteomics Reveals a Shift in Vitamin D-binding Protein and Antimicrobial Protein Axis in Tuberculosis Patients.Sci Rep. 2019 Jan 31;9(1):1036. doi: 10.1038/s41598-018-37662-9.
391 Human -defensin 1 update: Potential clinical applications of the restless warrior.Int J Biochem Cell Biol. 2018 Nov;104:133-137. doi: 10.1016/j.biocel.2018.09.007. Epub 2018 Sep 17.
392 Evidence that changes in antimicrobial peptides during tuberculosis are related to disease severity, clinical presentation, specific therapy and levels of immune-endocrine mediators.Cytokine. 2020 Feb;126:154913. doi: 10.1016/j.cyto.2019.154913. Epub 2019 Nov 12.
393 2-Mercapto-Quinazolinones as Inhibitors of Type II NADH Dehydrogenase and Mycobacterium tuberculosis: Structure-Activity Relationships, Mechanism of Action and Absorption, Distribution, Metabolism, and Excretion Characterization.ACS Infect Dis. 2018 Jun 8;4(6):954-969. doi: 10.1021/acsinfecdis.7b00275. Epub 2018 Mar 26.
394 MIR144* inhibits antimicrobial responses against Mycobacterium tuberculosis in human monocytes and macrophages by targeting the autophagy protein DRAM2.Autophagy. 2017 Feb;13(2):423-441. doi: 10.1080/15548627.2016.1241922. Epub 2016 Oct 20.
395 Tuberculosis serosurveillance and management practices of captive African elephants (Loxodonta africana) in the Kavango-Zambezi Transfrontier Conservation Area.Transbound Emerg Dis. 2018 Apr;65(2):e344-e354. doi: 10.1111/tbed.12764. Epub 2017 Nov 16.
396 Disputed rpoB mutations can frequently cause important rifampicin resistance among new tuberculosis patients.Int J Tuberc Lung Dis. 2015 Feb;19(2):185-90. doi: 10.5588/ijtld.14.0651.
397 A Novel Genetic Variation in NCF2, the Core Component of NADPH Oxidase, Contributes to the Susceptibility of Tuberculosis in Western Chinese Han Population.DNA Cell Biol. 2020 Jan;39(1):57-62. doi: 10.1089/dna.2019.5082. Epub 2019 Dec 2.
398 Biophysical characterization and ligand-binding properties of the elongation factor Tu from Mycobacterium tuberculosis.Acta Biochim Biophys Sin (Shanghai). 2019 Feb 1;51(2):139-149. doi: 10.1093/abbs/gmy164.
399 Crystal structure of Mycobacterium tuberculosis FadB2 implicated in mycobacterial -oxidation.Acta Crystallogr D Struct Biol. 2019 Jan 1;75(Pt 1):101-108. doi: 10.1107/S2059798318017242. Epub 2019 Jan 8.
400 Automated broth-based systems versus the MYCOTB plate for antimicrobial susceptibility testing of the Mycobacterium tuberculosis complex: challenges in interpretation.Diagn Microbiol Infect Dis. 2018 May;91(1):38-41. doi: 10.1016/j.diagmicrobio.2018.01.002. Epub 2018 Jan 6.
401 Migration and health: A retrospective study about the prevalence of HBV, HIV, HCV, tuberculosis and syphilis infections amongst newly arrived migrants screened at the Infectious Diseases Unit of Modena, Italy.J Infect Public Health. 2019 Mar-Apr;12(2):200-204. doi: 10.1016/j.jiph.2018.10.004. Epub 2018 Oct 28.
402 Micro-PET imaging of [18F]fluoroacetate combined with [18F]FDG to differentiate chronic Mycobacterium tuberculosis infection from an acute bacterial infection in a mouse model: a preliminary study.Nucl Med Commun. 2019 Jun;40(6):639-644. doi: 10.1097/MNM.0000000000001017.
403 Mycobacterial MenJ: An Oxidoreductase Involved in Menaquinone Biosynthesis.ACS Chem Biol. 2018 Sep 21;13(9):2498-2507. doi: 10.1021/acschembio.8b00402. Epub 2018 Aug 27.
404 Mycobacterium tuberculosis Drives Expansion of Low-Density Neutrophils Equipped With Regulatory Activities.Front Immunol. 2019 Nov 27;10:2761. doi: 10.3389/fimmu.2019.02761. eCollection 2019.
405 No Strong Relationship Between Components of the Lectin Pathway of Complement and Susceptibility to Pulmonary Tuberculosis.Inflammation. 2015 Aug;38(4):1731-7. doi: 10.1007/s10753-015-0150-0.
406 Correlation analysis between SNPs in microRNA-machinery genes and tuberculosis susceptibility in the Chinese Uygur population.Medicine (Baltimore). 2018 Dec;97(52):e13637. doi: 10.1097/MD.0000000000013637.
407 Common Variants in the Glycerol Kinase Gene Reduce Tuberculosis Drug Efficacy.mBio. 2019 Jul 30;10(4):e00663-19. doi: 10.1128/mBio.00663-19.
408 1, 25-dihydroxyvitamin D(3) downregulates cytotoxic effector response in pulmonary tuberculosis.Int Immunopharmacol. 2018 Sep;62:251-260. doi: 10.1016/j.intimp.2018.07.018. Epub 2018 Jul 20.
409 A real-time PCR signature to discriminate between tuberculosis and other pulmonary diseases.Tuberculosis (Edinb). 2015 Jul;95(4):421-5. doi: 10.1016/j.tube.2015.04.008. Epub 2015 May 14.
410 Development and psychometric testing of the Knowledge, Attitudes and Practices (KAP) questionnaire among student Tuberculosis (TB) Patients (STBP-KAPQ) in China.BMC Infect Dis. 2018 May 8;18(1):213. doi: 10.1186/s12879-018-3122-9.
411 DAP10 contributes to CD8(+) T cell-mediated cytotoxic effector mechanisms during Mycobacterium tuberculosis infection.Immunobiology. 2011 May;216(5):639-47. doi: 10.1016/j.imbio.2010.09.010. Epub 2010 Sep 24.
412 Lipid droplet formation in Mycobacterium tuberculosis infected macrophages requires IFN-/HIF-1 signaling and supports host defense.PLoS Pathog. 2018 Jan 25;14(1):e1006874. doi: 10.1371/journal.ppat.1006874. eCollection 2018 Jan.
413 Structure Determination of Mycobacterium tuberculosis Serine Protease Hip1 (Rv2224c).Biochemistry. 2017 May 2;56(17):2304-2314. doi: 10.1021/acs.biochem.6b01066. Epub 2017 Apr 7.
414 An exome wide association study of pulmonary tuberculosis patients and their asymptomatic household contacts.Infect Genet Evol. 2019 Jul;71:76-81. doi: 10.1016/j.meegid.2019.03.006. Epub 2019 Mar 18.
415 HLA-E-restricted CD8(+) T Lymphocytes Efficiently Control Mycobacterium tuberculosis and HIV-1 Coinfection.Am J Respir Cell Mol Biol. 2020 Apr;62(4):430-439. doi: 10.1165/rcmb.2019-0261OC.
416 Avoiding Antibiotic Inactivation in Mycobacterium tuberculosis by Rv3406 through Strategic Nucleoside Modification.ACS Infect Dis. 2018 Jul 13;4(7):1102-1113. doi: 10.1021/acsinfecdis.8b00038. Epub 2018 Apr 17.
417 Modulation of iron status biomarkers in tuberculosis-diabetes co-morbidity.Tuberculosis (Edinb). 2018 Jan;108:127-135. doi: 10.1016/j.tube.2017.11.011. Epub 2017 Nov 24.
418 Genetic sequencing for surveillance of drug resistance in tuberculosis in highly endemic countries: a multi-country population-based surveillance study.Lancet Infect Dis. 2018 Jun;18(6):675-683. doi: 10.1016/S1473-3099(18)30073-2. Epub 2018 Mar 21.
419 Peptide 19 of Porphyromonas gingivalis Heat Shock Protein Is a Potent Inducer of Low-Density Lipoprotein Oxidation.J Periodontol. 2017 Feb;88(2):e58-e64. doi: 10.1902/jop.2016.160402. Epub 2016 Oct 7.
420 Heat shock proteins: A dual carrier-adjuvant for an anti-drug vaccine against heroin.Bioorg Med Chem. 2019 Jan 1;27(1):125-132. doi: 10.1016/j.bmc.2018.11.027. Epub 2018 Nov 20.
421 Association of CD209 and CD209L polymorphisms with tuberculosis infection in a Northeastern Brazilian population.Mol Biol Rep. 2014 Aug;41(8):5449-57. doi: 10.1007/s11033-014-3416-y. Epub 2014 May 30.
422 Structure-based virtual screening, molecular dynamics simulation and MM-PBSA toward identifying the inhibitors for two-component regulatory system protein NarL of Mycobacterium Tuberculosis.J Biomol Struct Dyn. 2020 Jul;38(11):3396-3410. doi: 10.1080/07391102.2019.1657499. Epub 2019 Aug 26.
423 Gene expression profiling meta-analysis reveals novel gene signatures and pathways shared between tuberculosis and rheumatoid arthritis.PLoS One. 2019 Mar 7;14(3):e0213470. doi: 10.1371/journal.pone.0213470. eCollection 2019.
424 IL-18/IL-37/IP-10 signalling complex as a potential biomarker for discriminating active and latent TB.PLoS One. 2019 Dec 10;14(12):e0225556. doi: 10.1371/journal.pone.0225556. eCollection 2019.
425 A proline deletion in IFNAR1 impairs IFN-signaling and underlies increased resistance to tuberculosis in humans.Nat Commun. 2018 Jan 8;9(1):85. doi: 10.1038/s41467-017-02611-z.
426 Cross-resistance of isoniazid, para-aminosalicylic acid and pasiniazid against isoniazid-resistant Mycobacterium tuberculosis isolates in China.J Glob Antimicrob Resist. 2020 Mar;20:275-281. doi: 10.1016/j.jgar.2019.08.005. Epub 2019 Aug 16.
427 Epidemiology and outcome of HIV patients in Finland co-infected with tuberculosis 1998-2015.BMC Infect Dis. 2019 Mar 18;19(1):264. doi: 10.1186/s12879-019-3890-x.
428 Effective expansion of forkhead box P3?regulatory T cells via early secreted antigenic target 6 and antigen 85 complex B from Mycobacterium tuberculosis.Mol Med Rep. 2015 Apr;11(4):3134-42. doi: 10.3892/mmr.2014.3033. Epub 2014 Dec 3.
429 STAT3 expression by myeloid cells is detrimental for the T- cell-mediated control of infection with Mycobacterium tuberculosis.PLoS Pathog. 2018 Jan 16;14(1):e1006809. doi: 10.1371/journal.ppat.1006809. eCollection 2018 Jan.
430 Development of a single multiplex amplification refractory mutation system PCR for the detection of rifampin-resistant Mycobacterium tuberculosis.Gene. 2013 Nov 1;530(1):95-9. doi: 10.1016/j.gene.2013.07.060. Epub 2013 Aug 19.
431 Diagnostic accuracy of a selected signature gene set that discriminates active pulmonary tuberculosis and other pulmonary diseases.J Infect. 2017 Dec;75(6):499-510. doi: 10.1016/j.jinf.2017.09.012. Epub 2017 Sep 20.
432 In vivo virulence of Mycobacterium tuberculosis depends on a single homologue of the LytR-CpsA-Psr proteins.Sci Rep. 2018 Mar 2;8(1):3936. doi: 10.1038/s41598-018-22012-6.
433 Kallikrein 12 Regulates Innate Resistance of Murine Macrophages against Mycobacterium bovis Infection by Modulating Autophagy and Apoptosis.Cells. 2019 May 5;8(5):415. doi: 10.3390/cells8050415.
434 Analysis of the Phenotype of Mycobacterium tuberculosis-Specific CD4+ T Cells to Discriminate Latent from Active Tuberculosis in HIV-Uninfected and HIV-Infected Individuals.Front Immunol. 2017 Aug 10;8:968. doi: 10.3389/fimmu.2017.00968. eCollection 2017.
435 Two-Hit in vitro T-Cell Stimulation Detects Mycobacterium tuberculosis Infection in QuantiFERON Negative Tuberculosis Patients and Healthy Contacts From Ghana.Front Immunol. 2019 Jul 3;10:1518. doi: 10.3389/fimmu.2019.01518. eCollection 2019.
436 Secretion of IFN- Associated with Galectin-9 Production by Pleural Fluid Cells from a Patient with Extrapulmonary Tuberculosis.Int J Mol Sci. 2017 Jun 28;18(7):1382. doi: 10.3390/ijms18071382.
437 Clinical significance of lnc-AC145676.2.1-6 and lnc-TGS1-1 and their variants in western Chinese tuberculosis patients.Int J Infect Dis. 2019 Jul;84:8-14. doi: 10.1016/j.ijid.2019.04.018. Epub 2019 Apr 24.
438 Genetic Polymorphisms in Antioxidant Enzymes Modulate the Susceptibility of Idiosyncratic Antituberculous Drug-Induced Liver Injury and Treatment Outcomes in Patients with Tuberculosis.Pharmacotherapy. 2020 Jan;40(1):4-16. doi: 10.1002/phar.2349. Epub 2019 Dec 12.
439 Oxidization of TGF-activated kinase by MPT53 is required for immunity to Mycobacterium tuberculosis.Nat Microbiol. 2019 Aug;4(8):1378-1388. doi: 10.1038/s41564-019-0436-3. Epub 2019 May 20.
440 Discovery and validation of a prognostic proteomic signature for tuberculosis progression: A prospective cohort study.PLoS Med. 2019 Apr 16;16(4):e1002781. doi: 10.1371/journal.pmed.1002781. eCollection 2019 Apr.
441 AmpliSeq Screening of Genes Encoding the C-Type Lectin Receptors and Their Signaling Components Reveals a Common Variant in MASP1 Associated with Pulmonary Tuberculosis in an Indian Population.Front Immunol. 2018 Feb 20;9:242. doi: 10.3389/fimmu.2018.00242. eCollection 2018.
442 Serum antibody profiles in individuals with latent Mycobacterium tuberculosis infection.Microbiol Immunol. 2019 Mar;63(3-4):130-138. doi: 10.1111/1348-0421.12674. Epub 2019 Apr 9.
443 Positive association between MIC gene polymorphism and tuberculosis in Chinese population.Immunol Lett. 2019 Sep;213:62-69. doi: 10.1016/j.imlet.2019.07.008. Epub 2019 Aug 7.
444 Association between RANTES functional polymorphisms and tuberculosis in Hong Kong Chinese.Genes Immun. 2007 Sep;8(6):475-9. doi: 10.1038/sj.gene.6364412. Epub 2007 Jul 12.
445 Susceptibility of Mycobacterium tuberculosis-infected host cells to phospho-MLKL driven necroptosis is dependent on cell type and presence of TNF.Virulence. 2017 Nov 17;8(8):1820-1832. doi: 10.1080/21505594.2017.1377881. Epub 2017 Nov 24.
446 Second-line anti-tuberculosis drug resistance testing in Ghana identifies the first extensively drug-resistant tuberculosis case.Infect Drug Resist. 2018 Feb 22;11:239-246. doi: 10.2147/IDR.S152720. eCollection 2018.
447 A polymorphism in human MR1 is associated with mRNA expression and susceptibility to tuberculosis.Genes Immun. 2017 Jan;18(1):8-14. doi: 10.1038/gene.2016.41. Epub 2016 Nov 24.
448 Chemistry and Redox Biology of Mycothiol.Antioxid Redox Signal. 2018 Feb 20;28(6):487-504. doi: 10.1089/ars.2017.7074. Epub 2017 May 10.
449 Mutation at G103 of MtbFtsZ Altered their Sensitivity to Coumarins.Front Microbiol. 2017 Apr 6;8:578. doi: 10.3389/fmicb.2017.00578. eCollection 2017.
450 Association between common telomere length genetic variants and telomere length in an African population and impacts of HIV and TB.J Hum Genet. 2019 Oct;64(10):1033-1040. doi: 10.1038/s10038-019-0646-9. Epub 2019 Aug 6.
451 Identification of 9-oxo-1,2,3,4,5,6,10,19-octanor-13,17-secoandrost-8(14)-ene-7,17-dioic acid as a metabolite of steroid degradation in Comamonas testosteroni TA441 and the genes involved in the conversion.J Steroid Biochem Mol Biol. 2019 Jan;185:268-276. doi: 10.1016/j.jsbmb.2018.07.009. Epub 2018 Jul 17.
452 Synthesis, biological evaluation and in silico molecular modeling of pyrrolyl benzohydrazide derivatives as enoyl ACP reductase inhibitors.Eur J Med Chem. 2017 Jan 27;126:286-297. doi: 10.1016/j.ejmech.2016.11.032. Epub 2016 Nov 17.
453 Mortality in children diagnosed with tuberculosis: a systematic review and meta-analysis.Lancet Infect Dis. 2017 Mar;17(3):285-295. doi: 10.1016/S1473-3099(16)30474-1. Epub 2016 Dec 8.
454 Genome-Wide Association and Replication Study of Hepatotoxicity Induced by Antiretrovirals Alone or with Concomitant Anti-Tuberculosis Drugs.OMICS. 2017 Apr;21(4):207-216. doi: 10.1089/omi.2017.0019.
455 Case report of myeloperoxidase deficiency associated with disseminated paracoccidioidomycosis and peritoneal tuberculosis.Rev Soc Bras Med Trop. 2017 Jul-Aug;50(4):568-570. doi: 10.1590/0037-8682-0462-2016.
456 NLRC3 negatively regulates CD4+ T cells and impacts protective immunity during Mycobacterium tuberculosis infection.PLoS Pathog. 2018 Aug 22;14(8):e1007266. doi: 10.1371/journal.ppat.1007266. eCollection 2018 Aug.
457 A Common NLRC4 Gene Variant Associates With Inflammation and Pulmonary Function in Human Immunodeficiency Virus and Tuberculosis.Clin Infect Dis. 2020 Aug 14;71(4):924-932. doi: 10.1093/cid/ciz898.
458 Interleukin-32 induces caspase-independent apoptosis mediated by N-Myc interactor in macrophages infected with Mycobacterium tuberculosis.FEBS J. 2019 Feb;286(3):572-583. doi: 10.1111/febs.14717. Epub 2018 Dec 26.
459 Interrelational changes in the epidemiology and clinical features of nontuberculous mycobacterial pulmonary disease and tuberculosis in a referral hospital in Japan.Respir Med. 2019 Jun;152:74-80. doi: 10.1016/j.rmed.2019.05.001. Epub 2019 May 8.
460 2'-5'-Oligoadenylate synthetase 1 polymorphisms are associated with tuberculosis: a case-control study.BMC Pulm Med. 2018 Nov 29;18(1):180. doi: 10.1186/s12890-018-0746-x.
461 The selective autophagy receptors Optineurin and p62 are both required for zebrafish host resistance to mycobacterial infection.PLoS Pathog. 2019 Feb 28;15(2):e1007329. doi: 10.1371/journal.ppat.1007329. eCollection 2019 Feb.
462 Prognostic value of the mitogen response in the interferon- release assay in patients with culture-confirmed tuberculosis.Respir Med. 2019 Oct-Nov;158:49-54. doi: 10.1016/j.rmed.2019.10.004. Epub 2019 Oct 7.
463 An Assay System for Point-of-Care Diagnosis of Tuberculosis using Commercially Manufactured PCB Technology.Sci Rep. 2017 Apr 6;7(1):685. doi: 10.1038/s41598-017-00783-8.
464 Identification of Rv0222 from RD4 as a novel serodiagnostic target for tuberculosis.Tuberculosis (Edinb). 2008 Jul;88(4):335-43. doi: 10.1016/j.tube.2007.12.001. Epub 2008 Feb 19.
465 Proteomic characterisation of bovine and avian purified protein derivatives and identification of specific antigens for serodiagnosis of bovine tuberculosis.Clin Proteomics. 2017 Nov 2;14:36. doi: 10.1186/s12014-017-9171-z. eCollection 2017.
466 Tuberculosis case finding: Supplement intensified case finding among acute lower respiratory infection (ALRI) hospitalized patients in Sa Kaeo province, Thailand.J Formos Med Assoc. 2019 Aug;118(8):1255-1265. doi: 10.1016/j.jfma.2018.11.016. Epub 2019 Jan 10.
467 Structural basis for lipid binding and mechanism of the Mycobacterium tuberculosis Rv3802 phospholipase.J Biol Chem. 2018 Jan 26;293(4):1363-1372. doi: 10.1074/jbc.RA117.000240. Epub 2017 Dec 15.
468 Genetic polymorphisms of long noncoding RNA RP11-37B2.1 associate with susceptibility of tuberculosis and adverse events of antituberculosis drugs in west China.J Clin Lab Anal. 2019 Jun;33(5):e22880. doi: 10.1002/jcla.22880. Epub 2019 Mar 28.
469 Assessing and screening for T-cell epitopes from Mycobacterium tuberculosis RD2 proteins for the diagnosis of active tuberculosis.Braz J Infect Dis. 2018 Nov-Dec;22(6):462-471. doi: 10.1016/j.bjid.2018.10.280. Epub 2018 Dec 5.
470 Association between the PTPN22 1858C/T gene polymorphism and tuberculosis resistance.Infect Genet Evol. 2013 Jun;16:310-3. doi: 10.1016/j.meegid.2013.02.019. Epub 2013 Mar 14.
471 Exosomes function in antigen presentation during an in vivo Mycobacterium tuberculosis infection.Sci Rep. 2017 Mar 6;7:43578. doi: 10.1038/srep43578.
472 Ribokinase screened from T7 phage displayed Mycobacterium tuberculosis genomic DNA library had good potential for the serodiagnosis of tuberculosis.Appl Microbiol Biotechnol. 2019 Jul;103(13):5259-5267. doi: 10.1007/s00253-019-09756-5. Epub 2019 May 8.
473 Division of labor among Mycobacterium smegmatis RNase H enzymes: RNase H1 activity of RnhA or RnhC is essential for growth whereas RnhB and RnhA guard against killing by hydrogen peroxide in stationary phase.Nucleic Acids Res. 2017 Jan 9;45(1):1-14. doi: 10.1093/nar/gkw1046. Epub 2016 Nov 28.
474 Structural insights into the complex of trigger factor chaperone and ribosomal protein S7 from Mycobacterium tuberculosis.Biochem Biophys Res Commun. 2019 May 14;512(4):838-844. doi: 10.1016/j.bbrc.2019.03.166. Epub 2019 Mar 28.
475 Resolvin D1 (RvD1) and maresin 1 (Mar1) contribute to human macrophage control of M. tuberculosis infection while resolving inflammation.Int Immunopharmacol. 2019 Sep;74:105694. doi: 10.1016/j.intimp.2019.105694. Epub 2019 Jun 19.
476 Bayesian inference of transmission chains using timing of symptoms, pathogen genomes and contact data.PLoS Comput Biol. 2019 Mar 29;15(3):e1006930. doi: 10.1371/journal.pcbi.1006930. eCollection 2019 Mar.
477 Rifampin resistance, Beijing-W clade-single nucleotide polymorphism cluster group 2 phylogeny, and the Rv2629 191-C allele in Mycobacterium tuberculosis strains.J Clin Microbiol. 2008 Aug;46(8):2555-60. doi: 10.1128/JCM.00666-08. Epub 2008 Jun 11.
478 Differential thermal stability, conformational stability and unfolding behavior of Eis proteins from Mycobacterium smegmatis and Mycobacterium tuberculosis.PLoS One. 2019 Mar 25;14(3):e0213933. doi: 10.1371/journal.pone.0213933. eCollection 2019.
479 Molecular modelling and simulation studies of the Mycobacterium tuberculosis multidrug efflux pump protein Rv1258c.PLoS One. 2018 Nov 26;13(11):e0207605. doi: 10.1371/journal.pone.0207605. eCollection 2018.
480 Functional Analysis of Genetic Variations in Surfactant Protein D in Mycobacterial Infection and Their Association With Tuberculosis.Front Immunol. 2018 Jul 2;9:1543. doi: 10.3389/fimmu.2018.01543. eCollection 2018.
481 Restimulation-induced T-cell death through NTB-A/SAP signaling pathway is impaired in tuberculosis patients with depressed immune responses.Immunol Cell Biol. 2017 Sep;95(8):716-728. doi: 10.1038/icb.2017.42. Epub 2017 May 26.
482 Polymorphisms in SIGLEC1 contribute to susceptibility to pulmonary active tuberculosis possibly through the modulation of IL-1.Infect Genet Evol. 2017 Nov;55:313-317. doi: 10.1016/j.meegid.2017.09.031. Epub 2017 Sep 28.
483 Genetic Structure and Drug Susceptibility Patterns of Mycobacterium tuberculosis Complex Strains Responsible of Human Pulmonary Tuberculosis in the Major Rearing Region in Cameroon.Biomed Res Int. 2016;2016:2904832. doi: 10.1155/2016/2904832. Epub 2016 Dec 29.
484 Newly synthesized surfactants for surface mannosylation of respirable SLN assemblies to target macrophages in tuberculosis therapy.Drug Deliv Transl Res. 2019 Feb;9(1):298-310. doi: 10.1007/s13346-018-00607-w.
485 GSTM1 and GSTT1 genetic polymorphisms and risk of anti-tuberculosis drug-induced hepatotoxicity: an updated meta-analysis.Eur J Clin Microbiol Infect Dis. 2013 Jul;32(7):859-68. doi: 10.1007/s10096-013-1831-y. Epub 2013 Feb 2.
486 Comparison of loop-mediated isothermal amplification assay and smear microscopy with culture for the diagnostic accuracy of tuberculosis.BMC Infect Dis. 2017 Jan 17;17(1):79. doi: 10.1186/s12879-016-2140-8.
487 SMS nudges as a tool to reduce tuberculosis treatment delay and pretreatment loss to follow-up. A randomized controlled trial.PLoS One. 2019 Jun 20;14(6):e0218527. doi: 10.1371/journal.pone.0218527. eCollection 2019.
488 The Ubiquitin Ligase Smurf1 Functions in Selective Autophagy of Mycobacterium tuberculosis and Anti-tuberculous Host Defense.Cell Host Microbe. 2017 Jan 11;21(1):59-72. doi: 10.1016/j.chom.2016.11.002. Epub 2016 Dec 22.
489 Association between SLC11A1 (NRAMP1) polymorphisms and susceptibility to tuberculosis in Chinese Holstein cattle.Tuberculosis (Edinb). 2017 Mar;103:10-15. doi: 10.1016/j.tube.2016.11.003. Epub 2016 Nov 9.
490 Suppressors of cytokine signaling in tuberculosis.PLoS One. 2017 Apr 21;12(4):e0176377. doi: 10.1371/journal.pone.0176377. eCollection 2017.
491 Expression Profile of Three Splicing Factors in Pleural Cells Based on the Underlying Etiology and Its Clinical Values in Patients with Pleural Effusion.Transl Oncol. 2018 Feb;11(1):147-156. doi: 10.1016/j.tranon.2017.12.005. Epub 2017 Dec 27.
492 Reciprocal control of Mycobacterium avium and Mycobacterium tuberculosis infections by the alleles of the classic Class II H2-A gene in mice.Infect Genet Evol. 2019 Oct;74:103933. doi: 10.1016/j.meegid.2019.103933. Epub 2019 Jun 20.
493 Ga(III) Nanoparticles Inhibit Growth of both Mycobacterium tuberculosis and HIV and Release of Interleukin-6 (IL-6) and IL-8 in Coinfected Macrophages.Antimicrob Agents Chemother. 2017 Mar 24;61(4):e02505-16. doi: 10.1128/AAC.02505-16. Print 2017 Apr.
494 Rapid detection of Mycobacterium tuberculosis in sputum with a solvatochromic trehalose probe.Sci Transl Med. 2018 Feb 28;10(430):eaam6310. doi: 10.1126/scitranslmed.aam6310.
495 Magnitude of delayed turnaround time of laboratory results in Amhara Public Health Institute, Bahir Dar, Ethiopia.BMC Health Serv Res. 2019 Apr 24;19(1):240. doi: 10.1186/s12913-019-4077-2.
496 Epidemiological and spatial factors for tuberculosis: a matched case-control study in Nagata, Japan.Int J Tuberc Lung Dis. 2019 Feb 1;23(2):181-186. doi: 10.5588/ijtld.18.0369.
497 Polymorphisms in TICAM2 and IL1B are associated with TB.Genes Immun. 2015 Mar;16(2):127-133. doi: 10.1038/gene.2014.77. Epub 2014 Dec 18.
498 Dual color fluorescence in situ hybridization (FISH) assays for detecting Mycobacterium tuberculosis and Mycobacterium avium complexes and related pathogens in cultures.PLoS One. 2017 Apr 11;12(4):e0174989. doi: 10.1371/journal.pone.0174989. eCollection 2017.
499 Polymorphisms in Toll-Like Receptor 10 and Tuberculosis Susceptibility: Evidence from Three Independent Series.Front Immunol. 2018 Feb 23;9:309. doi: 10.3389/fimmu.2018.00309. eCollection 2018.
500 Host resistance to pulmonary Mycobacterium tuberculosis infection requires CD153 expression.Nat Microbiol. 2018 Nov;3(11):1198-1205. doi: 10.1038/s41564-018-0231-6. Epub 2018 Sep 10.
501 Evaluation of TLR2, TLR4, and TOLLIP polymorphisms for their role in tuberculosis susceptibility.APMIS. 2018 Jun;126(6):501-508. doi: 10.1111/apm.12855.
502 Gene expression profiling of the TRIM protein family reveals potential biomarkers for indicating tuberculosis status.Microb Pathog. 2018 Jan;114:385-392. doi: 10.1016/j.micpath.2017.12.008. Epub 2017 Dec 7.
503 Galectins and TRIMs directly interact and orchestrate autophagic response to endomembrane damage.Autophagy. 2017 Jun 3;13(6):1086-1087. doi: 10.1080/15548627.2017.1307487. Epub 2017 Apr 3.
504 TRIM22 regulates macrophage autophagy and enhances Mycobacterium tuberculosis clearance by targeting the nuclear factor-multiplicity B/beclin 1 pathway.J Cell Biochem. 2018 Nov;119(11):8971-8980. doi: 10.1002/jcb.27153. Epub 2018 Jul 16.
505 Incidence of tuberculosis among HIV infected individuals on long term antiretroviral therapy in private healthcare sector in Pune, Western India.BMC Infect Dis. 2019 Aug 13;19(1):714. doi: 10.1186/s12879-019-4361-0.
506 Mutations in lysX as the new and reliable markers for tuberculosis Beijing and modern Beijing strains.Tuberculosis (Edinb). 2016 Mar;97:33-7. doi: 10.1016/j.tube.2015.12.006. Epub 2015 Dec 29.
507 Construction of human MASP-2-CCP1/2SP, CCP2SP, SP plasmid DNA nanolipoplexes and the effects on tuberculosis in BCG-infected mice.Microb Pathog. 2017 Aug;109:200-208. doi: 10.1016/j.micpath.2017.05.043. Epub 2017 May 31.
508 Diagnostic accuracy study of multiplex PCR for detecting tuberculosis drug resistance.J Infect. 2015 Aug;71(2):220-30. doi: 10.1016/j.jinf.2015.03.011. Epub 2015 Apr 30.
509 Discriminative expression of whole blood genes in HIV patients with latent and active TB in Ethiopia.Tuberculosis (Edinb). 2016 Sep;100:25-31. doi: 10.1016/j.tube.2016.06.003. Epub 2016 Jun 13.
510 MiR-381-3p Regulates the Antigen-Presenting Capability of Dendritic Cells and Represses Antituberculosis Cellular Immune Responses by Targeting CD1c.J Immunol. 2016 Jul 15;197(2):580-9. doi: 10.4049/jimmunol.1500481. Epub 2016 Jun 13.
511 Heterozygote Advantage of the rs3794624 Polymorphism in CYBA for Resistance to Tuberculosis in Two Chinese Populations.Sci Rep. 2016 Nov 30;6:38213. doi: 10.1038/srep38213.
512 A Multistage Subunit Vaccine Effectively Protects Mice Against Primary Progressive Tuberculosis, Latency and Reactivation.EBioMedicine. 2017 Aug;22:143-154. doi: 10.1016/j.ebiom.2017.07.005. Epub 2017 Jul 8.
513 Down-regulation of N-acetylglucosamine-1-phosphate transferase (WecA) enhanced the sensitivity of Mycobacterium smegmatis against rifampin.J Appl Microbiol. 2016 Oct;121(4):966-72. doi: 10.1111/jam.13228. Epub 2016 Aug 21.
514 The Epigenetic Modifications of Genes Associated with Tuberculosis Susceptibility and Implications for Epi-Drugs.Crit Rev Eukaryot Gene Expr. 2015;25(4):349-62. doi: 10.1615/critreveukaryotgeneexpr.2015014334.
515 Biophysical and immunological characterization of the ESX-4 system ESAT-6 family proteins Rv3444c and Rv3445c from Mycobacterium tuberculosis H37Rv.Tuberculosis (Edinb). 2018 Mar;109:85-96. doi: 10.1016/j.tube.2018.02.002. Epub 2018 Feb 13.
516 A New ESX-1 Substrate in Mycobacterium marinum That Is Required for Hemolysis but Not Host Cell Lysis.J Bacteriol. 2019 Jun 21;201(14):e00760-18. doi: 10.1128/JB.00760-18. Print 2019 Jul 15.
517 Predicting functional regulatory SNPs in the human antimicrobial peptide genes DEFB1 and CAMP in tuberculosis and HIV/AIDS.Comput Biol Chem. 2015 Dec;59 Pt A:117-25. doi: 10.1016/j.compbiolchem.2015.09.002. Epub 2015 Sep 9.
518 Analysis of IL-6, STAT3 and HSPA1L gene polymorphisms in anti-tuberculosis drug-induced hepatitis in a nested case-control study.PLoS One. 2015 Mar 19;10(3):e0118862. doi: 10.1371/journal.pone.0118862. eCollection 2015.
519 Host ICAMs play a role in cell invasion by Mycobacterium tuberculosis and Plasmodium falciparum.Nat Commun. 2015 Jan 14;6:6049. doi: 10.1038/ncomms7049.
520 A Syrian Refugee in Iraq Diagnosed as a Case of IL12RB1 Deficiency in Japan Using Dried Blood Spots.Front Immunol. 2019 Jan 25;10:58. doi: 10.3389/fimmu.2019.00058. eCollection 2019.
521 Microarray analysis of Mycobacterium tuberculosis-infected monocytes reveals IL26 as a new candidate gene for tuberculosis susceptibility.Immunology. 2015 Feb;144(2):291-301. doi: 10.1111/imm.12371.
522 Gene expression profiling identifies candidate biomarkers for active and latent tuberculosis.BMC Bioinformatics. 2016 Jan 11;17 Suppl 1(Suppl 1):3. doi: 10.1186/s12859-015-0848-x.
523 A disease spectrum for ITPA variation: advances in biochemical and clinical research.J Biomed Sci. 2016 Oct 22;23(1):73. doi: 10.1186/s12929-016-0291-y.
524 The human lung mucosa drives differential Mycobacterium tuberculosis infection outcome in the alveolar epithelium.Mucosal Immunol. 2019 May;12(3):795-804. doi: 10.1038/s41385-019-0156-2. Epub 2019 Mar 7.
525 Correlations between major risk factors and closely related Mycobacterium tuberculosis isolates grouped by three current genotyping procedures: a population-based study in northeast Mexico.Mem Inst Oswaldo Cruz. 2014 Sep;109(6):814-9. doi: 10.1590/0074-0276130550.
526 "The Impact of Mycobacterium tuberculosis Immune Evasion on Protective Immunity: Implications for TB Vaccine Design" - Meeting report.Vaccine. 2017 Jun 14;35(27):3433-3440. doi: 10.1016/j.vaccine.2017.04.007. Epub 2017 May 2.
527 Screening in planarians identifies MORN2 as a key component in LC3-associated phagocytosis and resistance to bacterial infection.Cell Host Microbe. 2014 Sep 10;16(3):338-50. doi: 10.1016/j.chom.2014.08.002.
528 Will the European Union reach the United Nations Millennium declaration target of a 50% reduction of tuberculosis mortality between 1990 and 2015?.BMC Public Health. 2017 Jul 6;17(1):629. doi: 10.1186/s12889-017-4544-9.
529 NF-B repressing factor downregulates basal expression and mycobacterium tuberculosis induced IP-10 and IL-8 synthesis via interference with NF-B in monocytes.J Biomed Sci. 2014 Aug 19;21(1):71. doi: 10.1186/s12929-014-0071-5.
530 Division site selection linked to inherited cell surface wave troughs in mycobacteria.Nat Microbiol. 2017 Jun 26;2:17094. doi: 10.1038/nmicrobiol.2017.94.
531 Biochemical and structural characterization of mycobacterial aspartyl-tRNA synthetase AspS, a promising TB drug target.PLoS One. 2014 Nov 19;9(11):e113568. doi: 10.1371/journal.pone.0113568. eCollection 2014.
532 A Rab20-Dependent Membrane Trafficking Pathway Controls M.tuberculosis Replication by Regulating Phagosome Spaciousness and Integrity.Cell Host Microbe. 2017 May 10;21(5):619-628.e5. doi: 10.1016/j.chom.2017.04.004.
533 Effect of Brazil's conditional cash transfer programme on tuberculosis incidence.Int J Tuberc Lung Dis. 2017 Jul 1;21(7):790-796. doi: 10.5588/ijtld.16.0599.
534 Incidence of active tuberculosis in individuals with latent tuberculosis infection in rural China: follow-up results of a population-based, multicentre, prospective cohort study.Lancet Infect Dis. 2017 Oct;17(10):1053-1061. doi: 10.1016/S1473-3099(17)30402-4. Epub 2017 Jul 14.
535 Association of autophagy-related IRGM polymorphisms with latent versus active tuberculosis infection in a Chinese population.Tuberculosis (Edinb). 2016 Mar;97:47-51. doi: 10.1016/j.tube.2016.01.001. Epub 2016 Jan 9.
536 The SIGLEC14 null allele is associated with Mycobacterium tuberculosis- and BCG-induced clinical and immunologic outcomes.Tuberculosis (Edinb). 2017 May;104:38-45. doi: 10.1016/j.tube.2017.02.005. Epub 2017 Feb 21.
537 Ras Signaling Inhibitors Attenuate Disease in Adjuvant-Induced Arthritis via Targeting Pathogenic Antigen-Specific Th17-Type Cells.Front Immunol. 2017 Jul 7;8:799. doi: 10.3389/fimmu.2017.00799. eCollection 2017.
538 Lateral Flow Urine Lipoarabinomannan Assay for Diagnosis of Active Tuberculosis in Adults With Human Immunodeficiency Virus Infection: A Prospective Cohort Study.Open Forum Infect Dis. 2019 Mar 15;6(4):ofz132. doi: 10.1093/ofid/ofz132. eCollection 2019 Apr.
539 Micronutrient supplementation in adults with HIV infection.Cochrane Database Syst Rev. 2017 May 18;5(5):CD003650. doi: 10.1002/14651858.CD003650.pub4.